{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":186,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":186,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"7c55eea1011c","filters":{"venue":"Cancer Chemotherapy and Pharmacology"}},"results":[{"id":"W2021381932","doi":"10.1007/s00280-006-0224-7","title":"Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene","year":2006,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":253,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Ottawa","keywords":"A549 cell; Gene silencing; RNA interference; Cisplatin; Doxorubicin; Cancer research; Transfection; Biology; MTT assay; Flow cytometry; Cell; Molecular biology; Cell culture; Chemistry; Chemotherapy; RNA; Gene; Biochemistry","authors":[{"name":"Xianrang Song","is_ca":false},{"name":"Xianxi Liu","is_ca":false},{"name":"Weiling Chi","is_ca":false},{"name":"Yonglei Liu","is_ca":false},{"name":"Ling Wei","is_ca":false},{"name":"Xingwu Wang","is_ca":false},{"name":"Jinming Yu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006711336621092121,"gpt":0.268401795022745,"spread":0.2616904584016529,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001396765,0.0002561856,0.0003764367,0.00009135834,0.00006399755,0.00001112223,0.0001271292,0.0002151562,0.0001395489],"category_scores_gemma":[0.000002852113,0.0002688918,0.0000512488,0.0002233053,0.00007914025,0.000007537484,0.00005226086,0.0001449197,3.172428e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004207188,"about_ca_system_score_gemma":0.0001290946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001192007,"about_ca_topic_score_gemma":0.0009486551,"domain_scores_codex":[0.998593,0.000050378,0.0003414671,0.0005478874,0.00008673862,0.0003805209],"domain_scores_gemma":[0.9994797,0.00002182156,0.0001529063,0.0001554393,0.00007426382,0.0001158361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004833159,0.00006060041,0.002881376,0.0001319667,0.00004585646,0.000001160428,0.0004606077,0.00004086374,0.9532806,0.000002045777,0.03925285,0.003358766],"study_design_scores_gemma":[0.003494348,0.00007978429,0.00390541,0.00004050699,0.00005165624,0.00000176398,0.00004052452,0.00009301877,0.952543,0.00001465166,0.03944866,0.0002867082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9504185,0.04734325,0.0001211636,0.0007082717,0.0005044517,0.0004699086,0.000146972,0.000007397586,0.000280077],"genre_scores_gemma":[0.974888,0.01805606,0.0003438251,0.004201457,0.0009286588,0.0001718832,0.00002318586,0.00004046044,0.001346484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02928719,"threshold_uncertainty_score":0.9999763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040176056","doi":"10.1007/s00280-009-1041-6","title":"A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Notre-Dame; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Lapatinib; Pharmacokinetics; Medicine; Toxicity; Pharmacology; Gastroenterology; Phases of clinical research; Internal medicine; Oral administration; Cancer; Breast cancer; Trastuzumab","authors":[{"name":"Brian Thiessen","is_ca":true},{"name":"Clinton F. Stewart","is_ca":false},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Paula Schaiquevich","is_ca":false},{"name":"Warren Mason","is_ca":true},{"name":"Jacob C. Easaw","is_ca":false},{"name":"Karl Bélanger","is_ca":true},{"name":"Peter Forsyth","is_ca":false},{"name":"L. McIntosh","is_ca":true},{"name":"Elizabeth A. Eisenhauer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02916190242965619,"gpt":0.4183574430505823,"spread":0.389195540620926,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001862588,0.0001768933,0.0005125653,0.0001142076,0.00003393174,0.000003850789,0.00003831388,0.0001254263,0.0002136979],"category_scores_gemma":[0.00001732092,0.0001292293,0.00009185547,0.0001293441,0.0001046956,0.00003690671,0.00001426326,0.0001852549,7.153284e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004260766,"about_ca_system_score_gemma":0.00006108458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001367149,"about_ca_topic_score_gemma":0.000006176808,"domain_scores_codex":[0.9988465,0.00007446583,0.000497415,0.000278652,0.000108975,0.0001940128],"domain_scores_gemma":[0.9994196,0.0001204069,0.0001764993,0.00008892584,0.00005313604,0.0001414009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09824826,0.01230354,0.03700138,0.00006279305,0.0003795817,0.00008231888,0.0005149629,0.00001180842,0.0769966,0.00004043502,0.001871793,0.7724865],"study_design_scores_gemma":[0.7706048,0.03628714,0.03310954,0.0001294571,0.000646791,0.0000258967,0.00002143986,0.00471476,0.1385519,0.0001379237,0.0154664,0.0003039014],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914737,0.002280501,0.00002328944,0.004603941,0.0005347071,0.0009912007,0.00002083432,0.00001543175,0.00005643858],"genre_scores_gemma":[0.9876,0.008831218,0.0001545873,0.003138896,0.0001442026,0.00008571372,0.000009664936,0.00001228535,0.00002339608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7721826,"threshold_uncertainty_score":0.5269818,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046529949","doi":"10.1007/s00280-010-1288-y","title":"An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Epirubicin; Toxicity; Pharmacokinetics; Lean body mass; Internal medicine; Medicine; Pharmacology; Endocrinology; Cancer; Breast cancer","authors":[{"name":"Carla M. Prado","is_ca":true},{"name":"Isac Lima","is_ca":true},{"name":"Vickie E. Baracos","is_ca":true},{"name":"Robert R. Bies","is_ca":false},{"name":"Linda J. McCargar","is_ca":true},{"name":"Tony Reiman","is_ca":true},{"name":"John R. Mackey","is_ca":true},{"name":"Michelle Kuzma","is_ca":true},{"name":"Vijaya L. Damaraju","is_ca":true},{"name":"Michael B. Sawyer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02030484285912247,"gpt":0.3738661671623288,"spread":0.3535613243032064,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001134499,0.0001289965,0.0003661118,0.00007332558,0.00003851219,0.000003026631,0.00005231265,0.00007603026,0.0004866695],"category_scores_gemma":[0.000001375669,0.0001119567,0.00002707413,0.00007459363,0.0001981406,0.00005734709,0.00001546293,0.0001989921,1.923973e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001452965,"about_ca_system_score_gemma":0.00006355128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000212026,"about_ca_topic_score_gemma":0.00008264636,"domain_scores_codex":[0.9992836,0.00004733297,0.0002346652,0.000211339,0.00009247957,0.0001305741],"domain_scores_gemma":[0.9995061,0.00003237491,0.0001355885,0.0001121964,0.00008083549,0.0001329773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001461582,0.0008629654,0.05676946,0.0001053009,0.0001107646,0.000006927609,0.003885842,0.000001895504,0.9186206,0.000004010141,0.00009668721,0.01807399],"study_design_scores_gemma":[0.007137182,0.00224899,0.0352777,0.00001759317,0.000229994,0.00001991868,0.0003556242,0.0004293863,0.9530838,0.00001605193,0.001078345,0.000105442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983764,0.000510925,0.0000118329,0.0001819574,0.0003394025,0.0005037338,0.00002056568,0.00001351042,0.00004170203],"genre_scores_gemma":[0.9966972,0.002008582,0.00003605929,0.0009883847,0.0001983471,0.00004066635,0.000003193427,0.00001682075,0.00001070972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0344632,"threshold_uncertainty_score":0.5328689,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014573616","doi":"10.1007/s00280-004-0947-2","title":"Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Geldanamycin; Hsp90; Heat shock protein; Hsp90 inhibitor; Cancer research; Clonogenic assay; Melanoma; Chemistry; In vitro; Biology; Biochemistry","authors":[{"name":"Victoria Smith","is_ca":false},{"name":"Edward A. Sausville","is_ca":false},{"name":"Richard F. Camalier","is_ca":false},{"name":"Heinz‐Herbert Fiebig","is_ca":false},{"name":"Angelika M. Burger","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02881835719658737,"gpt":0.3692101097795229,"spread":0.3403917525829355,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001099572,0.0005088301,0.0009152042,0.0003794363,0.000101254,0.00002556546,0.0002930619,0.0005754979,0.00009812354],"category_scores_gemma":[0.00005555075,0.0005006868,0.00008523405,0.000315034,0.0003748718,0.00003036383,0.0002086418,0.0006927829,8.577738e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001307637,"about_ca_system_score_gemma":0.0001849529,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002911532,"about_ca_topic_score_gemma":0.0005577772,"domain_scores_codex":[0.9964458,0.0006907285,0.0007316305,0.00104862,0.0002762869,0.0008069298],"domain_scores_gemma":[0.9988285,0.0002569999,0.0001944977,0.0003552357,0.0000916652,0.0002730782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001517303,0.0003562899,0.005791257,0.0002618784,0.0001285418,0.00001460789,0.0008633287,0.0006627151,0.8690757,0.00002520496,0.001299949,0.1200032],"study_design_scores_gemma":[0.006294478,0.001227839,0.00724952,0.00008707625,0.00003524835,0.00001071496,0.00008108285,0.007025017,0.9655852,0.0001452745,0.01178191,0.0004766806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9754456,0.01940604,0.0006682864,0.001660607,0.00009780348,0.001856809,0.00003560357,0.00001722493,0.0008119624],"genre_scores_gemma":[0.9874477,0.005607067,0.003045251,0.001967055,0.0003155015,0.0005995093,0.00003311662,0.00006636816,0.000918411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1195265,"threshold_uncertainty_score":0.9997445,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1994673341","doi":"10.1007/s00280-004-0939-2","title":"In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Geldanamycin; In vivo; Pharmacology; Derivative (finance); Chemistry; Hydrochloride; Medicine; Hsp90; Biochemistry; Biology; Heat shock protein","authors":[{"name":"Melinda G. Hollingshead","is_ca":false},{"name":"Michael C. Alley","is_ca":false},{"name":"Angelika M. Burger","is_ca":true},{"name":"Suzanne Borgel","is_ca":false},{"name":"Christine Pacula-Cox","is_ca":false},{"name":"Heinz‐Herbert Fiebig","is_ca":false},{"name":"Edward A. Sausville","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01534904627691841,"gpt":0.3122554470329186,"spread":0.2969064007560002,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003986567,0.0003705324,0.0005200423,0.0001492398,0.00008682558,0.00001614913,0.0003117037,0.0002772741,0.001609307],"category_scores_gemma":[0.000006990603,0.0003344634,0.0001359695,0.0001813697,0.0002232206,0.00002063954,0.0001130221,0.0002449649,0.000002568181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007574702,"about_ca_system_score_gemma":0.0001397446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001930891,"about_ca_topic_score_gemma":0.0003216519,"domain_scores_codex":[0.9979907,0.0001108277,0.0004867015,0.0006541663,0.0001545479,0.0006030595],"domain_scores_gemma":[0.999264,0.00005400478,0.00016472,0.0002797054,0.00009227814,0.0001452987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001076762,0.0002264973,0.0001761721,0.00004120202,0.0002482141,0.00000722655,0.0007934219,0.0003380749,0.9745371,0.00005003687,0.0102951,0.01221015],"study_design_scores_gemma":[0.003987168,0.0003415196,0.0001604568,0.00001674737,0.00004745348,0.000009982014,0.00004350309,0.000230261,0.7116151,0.0001056557,0.2831548,0.0002873247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880882,0.006704133,0.0007740795,0.002349435,0.0005942219,0.0005374025,0.00004117835,0.00001838604,0.0008929523],"genre_scores_gemma":[0.9738034,0.008319644,0.0008601285,0.009880979,0.001007629,0.0001626276,0.00003071385,0.00006829439,0.005866601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2728598,"threshold_uncertainty_score":0.9999107,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2885544802","doi":"10.1007/s00280-018-3654-0","title":"A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nucro Technics","funders":"Paracelsus Medizinische Privatuniversität","keywords":"Tolerability; Curcumin; Medicine; Pharmacokinetics; Hemolysis; Pharmacology; Toxicity; Adverse effect; Cancer; Pharmacodynamics; Phases of clinical research; Gastroenterology; Internal medicine","authors":[{"name":"Richard Greil","is_ca":false},{"name":"Sigrun Greil‐Ressler","is_ca":false},{"name":"Lukas Weiß","is_ca":false},{"name":"Charlotte Schönlieb","is_ca":false},{"name":"Teresa Magnes","is_ca":false},{"name":"B Radl","is_ca":false},{"name":"Gordon T. Bolger","is_ca":true},{"name":"Brigitta Vcelar","is_ca":false},{"name":"Peter P. Sordillo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01766075689360954,"gpt":0.3529491330209953,"spread":0.3352883761273858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001593094,0.0001523513,0.0002180567,0.00002958944,0.00007606141,0.000005552596,0.0001032184,0.00006027557,0.0002307437],"category_scores_gemma":[0.00001295809,0.00009625094,0.00001838205,0.000175959,0.0004597481,0.000007791312,0.00003939591,0.0001053303,3.337495e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003201385,"about_ca_system_score_gemma":0.000107652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007386733,"about_ca_topic_score_gemma":0.000265436,"domain_scores_codex":[0.9990448,0.0001190263,0.0001994871,0.0003621466,0.0001070036,0.00016759],"domain_scores_gemma":[0.9994703,0.00007248641,0.0001284985,0.0001665811,0.00009532033,0.0000668439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02719544,0.005477041,0.07691294,0.00006961736,0.0003689617,9.481102e-7,0.001207062,0.00002174939,0.6086316,0.00001225394,0.0003080221,0.2797943],"study_design_scores_gemma":[0.0351111,0.01183606,0.348071,0.00004669689,0.0001469627,0.000001514802,0.000158655,0.0005160695,0.5939061,0.00005615864,0.009785036,0.0003646991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967205,0.0001703614,0.0004185299,0.001304081,0.00006878591,0.001207603,0.00008374444,0.000005075722,0.00002134588],"genre_scores_gemma":[0.9983785,0.0002070973,0.00005065455,0.0008404272,0.00009683738,0.0003712941,0.00001087332,0.00001400914,0.00003036074],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2794296,"threshold_uncertainty_score":0.3924999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107882830","doi":"10.1007/s00280-008-0894-4","title":"The x c − cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine","year":2008,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Sulfur Compounds in Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Sulfasalazine; Antiporter; Glutamate receptor; Cystine; Medicine; Lung cancer; Cancer research; Pharmacology; Chemistry; Oncology; Internal medicine; Biochemistry; Membrane; Enzyme; Cysteine","authors":[{"name":"Jun Guan","is_ca":true},{"name":"Maisie Lo","is_ca":true},{"name":"Peter Dockery","is_ca":false},{"name":"Sarah Mahon","is_ca":false},{"name":"Cristina M. Karp","is_ca":false},{"name":"Arthur R. Buckley","is_ca":false},{"name":"Stephen Lam","is_ca":true},{"name":"Peter W. Gout","is_ca":true},{"name":"Yuzhuo Wang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02194531959709509,"gpt":0.3029447925616004,"spread":0.2809994729645053,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000142098,0.0002376068,0.0002837855,0.00003360094,0.0002491024,0.00001238397,0.0002460332,0.0002068276,0.0001370937],"category_scores_gemma":[0.000008561306,0.0001823383,0.0001200841,0.00007582949,0.0004623305,0.000005926712,0.00006227106,0.0001195978,5.833834e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002076219,"about_ca_system_score_gemma":0.0002141078,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007141198,"about_ca_topic_score_gemma":0.00001680463,"domain_scores_codex":[0.9987314,0.00009672953,0.0003009521,0.0004015043,0.0000647859,0.0004045783],"domain_scores_gemma":[0.9992424,0.00009520066,0.0002112263,0.000214299,0.0001609503,0.00007588036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001936873,0.00007454569,0.0102106,0.00005774482,0.0004045546,0.000004669437,0.0001077216,0.0001448333,0.9742838,0.00001319899,0.008508379,0.004253132],"study_design_scores_gemma":[0.003032367,0.0003987548,0.001399523,0.000005774592,0.00009181144,0.00005847132,0.00001151877,0.0008626159,0.789724,0.00006959178,0.2041298,0.0002157261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9679392,0.02743093,0.001476487,0.001307386,0.001077361,0.0006022911,0.0001074426,0.00001605587,0.00004287191],"genre_scores_gemma":[0.9476717,0.04566235,0.0005614656,0.003540745,0.0007203319,0.0003418838,0.00004750993,0.00004875929,0.001405219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1956214,"threshold_uncertainty_score":0.743554,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1549234286","doi":"10.1007/s00280-003-0609-9","title":"Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion","year":2003,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Berberine and alkaloids research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Sanguinarine; Cytotoxicity; Glutathione; Apoptosis; Programmed cell death; Cancer cell; Cell culture; DNA fragmentation; Molecular biology; Biology; Biochemistry; Chemistry; Pharmacology; In vitro; Alkaloid; Cancer; Enzyme","authors":[{"name":"Eric Débiton","is_ca":false},{"name":"Jean‐Claude Madelmont","is_ca":false},{"name":"Jean Legault","is_ca":false},{"name":"Chantal Barthomeuf","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02893210128765099,"gpt":0.3318070390997325,"spread":0.3028749378120815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001362575,0.0001550868,0.0002635781,0.00006379853,0.0001075116,0.00001628605,0.00003798497,0.0001282454,0.001841589],"category_scores_gemma":[0.000007345305,0.0001273067,0.00002459767,0.000185187,0.00009331459,0.00008112248,0.00001027807,0.0002499289,0.000002140362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000535698,"about_ca_system_score_gemma":0.00009465457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001418794,"about_ca_topic_score_gemma":0.00001547467,"domain_scores_codex":[0.9990796,0.0000886301,0.0001180117,0.000304586,0.000129228,0.0002799053],"domain_scores_gemma":[0.9995201,0.00003449223,0.00004863261,0.00009450853,0.0000964669,0.000205794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009384371,0.0002149457,0.03357117,0.00006953658,0.0003603591,0.00002604603,0.0009541372,5.78881e-7,0.9443906,0.00003132402,0.001256233,0.01818667],"study_design_scores_gemma":[0.01025134,0.002101107,0.01972509,0.00004390602,0.0001843038,0.0000494071,0.0001129219,0.0001193763,0.95196,0.0001018965,0.01507343,0.0002772755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963676,0.0009003265,0.00002335409,0.001553737,0.00006170303,0.0003239035,0.000008454302,0.00003637318,0.0007245868],"genre_scores_gemma":[0.9926689,0.001566905,0.0001027189,0.004126223,0.0001235235,0.00005782859,0.00001275141,0.00003130078,0.001309876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01790939,"threshold_uncertainty_score":0.9990709,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2064175713","doi":"10.1007/s002800100294","title":"Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells","year":2001,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Trichostatin A; DNA methylation; Molecular biology; Histone deacetylase; Cancer research; Biology; Histone deacetylase inhibitor; Retinoic acid receptor; Gene expression; Histone; Gene; Biochemistry","authors":[{"name":"Veronica Bovenzi","is_ca":true},{"name":"Richard L. Momparler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0106146836701716,"gpt":0.2797656123130053,"spread":0.2691509286428337,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001944437,0.0001585288,0.000216681,0.0000481181,0.00005164621,0.000005102114,0.0000441377,0.0001331108,0.00003865025],"category_scores_gemma":[0.000007980496,0.0001133524,0.00002481269,0.00006432252,0.0001899042,0.00000549798,0.00003545697,0.00008700012,1.086029e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001185082,"about_ca_system_score_gemma":0.00002443771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002629422,"about_ca_topic_score_gemma":0.000006356403,"domain_scores_codex":[0.9992244,0.0001422281,0.0001842177,0.0002691475,0.00004595876,0.0001340429],"domain_scores_gemma":[0.9995943,0.0000883409,0.0001351616,0.00008945142,0.00003634919,0.00005643232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001322881,0.00007093878,0.01650744,0.00008887029,0.00002406437,3.50309e-7,0.0001797613,0.0000052488,0.9633877,0.000001667719,0.0001278319,0.01828319],"study_design_scores_gemma":[0.00267537,0.000618303,0.003231584,0.00003731996,0.00001680585,0.000006556121,0.00004066579,0.00006869297,0.9911008,0.000007871861,0.002089618,0.0001064361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827918,0.01637781,0.00002932145,0.0003375043,0.0001524676,0.0002584055,0.00003904862,0.000003005837,0.00001063446],"genre_scores_gemma":[0.9710642,0.02853522,0.00005255454,0.00009621816,0.0001707091,0.000029816,0.0000129182,0.00001566624,0.00002273261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02771302,"threshold_uncertainty_score":0.4622377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2091073184","doi":"10.1007/s00280-004-0941-8","title":"Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Chemical synthesis and alkaloids","field":"Chemistry","cited_by":112,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of Windsor","funders":"University of Windsor","keywords":"Apoptosis; Cancer cell; DNA fragmentation; DNA damage; Programmed cell death; Biology; Caspase; Cell biology; DNA; Cancer research; Molecular biology; Cancer; Biochemistry; Genetics","authors":[{"name":"Natasha Kekre","is_ca":true},{"name":"Carly Griffin","is_ca":true},{"name":"James McNulty","is_ca":true},{"name":"Siyaram Pandey","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01018464371079852,"gpt":0.2613468441754455,"spread":0.251162200464647,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001162309,0.0001501703,0.0003604684,0.00002884541,0.00005170157,0.000009592197,0.0001045683,0.00009474484,0.001783653],"category_scores_gemma":[0.000008137467,0.0001190446,0.00004766339,0.0001112441,0.0002838725,0.00006281104,0.00002271535,0.00009058096,1.765667e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000602596,"about_ca_system_score_gemma":0.00003200473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004054169,"about_ca_topic_score_gemma":0.00001481091,"domain_scores_codex":[0.9991313,0.00003531307,0.0003555455,0.0002153012,0.00008991757,0.0001725895],"domain_scores_gemma":[0.9993525,0.0002686514,0.0002033853,0.00009379779,0.00003257745,0.00004912722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005687998,0.0001155684,0.000912572,0.0001206208,0.00008628822,2.743397e-7,0.000813915,0.000006360657,0.9576634,0.00005079093,0.0008791068,0.03878232],"study_design_scores_gemma":[0.005502209,0.0000249273,0.0004405874,0.00004747464,0.00002514579,5.474761e-7,0.00007378776,0.0001054898,0.9864926,0.00004893326,0.007118366,0.0001199569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996343,0.001765038,0.00001699218,0.001236628,0.00002865279,0.0001224197,0.00004695954,0.000009934552,0.0004304468],"genre_scores_gemma":[0.9943866,0.004602822,0.00009647709,0.0004625857,0.0001590977,0.00005158769,0.000006472745,0.00001739931,0.0002170034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03866237,"threshold_uncertainty_score":0.9991289,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113716960","doi":"10.1007/s00280-010-1283-3","title":"Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Pharmacodynamics; Bortezomib; Dosing; Medicine; Multiple myeloma; Pharmacology; Toxicity; Proteasome inhibitor; Internal medicine","authors":[{"name":"Donna Reece","is_ca":true},{"name":"Dan M. Sullivan","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Ann Mohrbacher","is_ca":false},{"name":"Gurkamal Chatta","is_ca":false},{"name":"Chaim Shustik","is_ca":true},{"name":"Howard A. Burris","is_ca":false},{"name":"Karthik Venkatakrishnan","is_ca":false},{"name":"Rachel Neuwirth","is_ca":false},{"name":"William Riordan","is_ca":false},{"name":"Michael D. Karol","is_ca":false},{"name":"Lisa L. von Moltke","is_ca":false},{"name":"Milin Acharya","is_ca":false},{"name":"Peter Zannikos","is_ca":false},{"name":"A. Keith Stewart","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01165579831940681,"gpt":0.3369503887422675,"spread":0.3252945904228606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001061271,0.0001901727,0.0004542623,0.0001834378,0.00003519555,0.000003196156,0.00007309311,0.00005513799,0.0004554508],"category_scores_gemma":[0.000007986262,0.0001447683,0.00002580843,0.0002034096,0.0002359687,0.00006194653,0.00002970631,0.0002951047,3.680459e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002612774,"about_ca_system_score_gemma":0.00007730915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003697102,"about_ca_topic_score_gemma":0.0002396643,"domain_scores_codex":[0.9988901,0.0000687087,0.0002885622,0.000305425,0.0001869341,0.0002602578],"domain_scores_gemma":[0.9993393,0.0001231055,0.0001348269,0.0001215334,0.0001179669,0.0001632293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007052567,0.001760028,0.6711757,0.0001183805,0.0003513664,0.00001658208,0.0006352944,0.000006204048,0.280908,9.796461e-7,0.00002843077,0.03794646],"study_design_scores_gemma":[0.09634776,0.001733997,0.7804666,0.00002960389,0.0001818594,0.000004751525,0.00006637616,0.001048062,0.1198382,0.00000525534,0.0001623721,0.0001151109],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977601,0.000390876,0.000002087839,0.0001321712,0.0001407367,0.001448349,0.00003864877,0.00001277678,0.00007429773],"genre_scores_gemma":[0.9988017,0.0005955818,0.0001361136,0.0001995083,0.00005351533,0.0001300726,0.00001224214,0.00002647932,0.00004477585],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1610698,"threshold_uncertainty_score":0.5903479,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2091972238","doi":"10.1007/s002800100348","title":"The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity","year":2001,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Cardiotoxicity; Medicine; Doxorubicin; Mitoxantrone; Cardioprotection; Pharmacology; Chemotherapy; Cumulative dose; Urology; Internal medicine; Myocardial infarction; Anthracycline; Cancer","authors":[{"name":"Eugene H. Herman","is_ca":false},{"name":"Jun Zhang","is_ca":false},{"name":"Nader Rifai","is_ca":false},{"name":"Steven E. Lipshultz","is_ca":false},{"name":"Brian B. Hasinoff","is_ca":true},{"name":"Douglas P. Chadwick","is_ca":false},{"name":"Alan Knapton","is_ca":false},{"name":"Jonathan Chai","is_ca":false},{"name":"Victor J. Ferrans","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06302401746380445,"gpt":0.3387333388777059,"spread":0.2757093214139015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003572789,0.0002200982,0.0007511415,0.00006973051,0.0001551236,0.000008974009,0.0001106878,0.0001117577,0.0000356471],"category_scores_gemma":[0.00002899498,0.0001461504,0.0001686365,0.0003019751,0.0004081153,0.00007982463,0.00003940515,0.0002945545,1.564709e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009703176,"about_ca_system_score_gemma":0.0001640013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002592586,"about_ca_topic_score_gemma":0.00007852643,"domain_scores_codex":[0.9986266,0.0002655464,0.0003266891,0.0002890734,0.0002161131,0.000275952],"domain_scores_gemma":[0.9987478,0.0003735636,0.0002648569,0.0002650579,0.0002336821,0.0001150348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001891366,0.00006959073,0.003308746,0.0001108165,0.0007429814,0.000001408266,0.001588156,0.00005694248,0.869428,0.00001267699,0.0001468387,0.1226425],"study_design_scores_gemma":[0.002166015,0.0003089088,0.07866196,0.00007418473,0.0001755766,0.00001254231,0.0002373862,0.0001489592,0.9143242,0.00002016533,0.003748164,0.0001218985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933186,0.001278663,0.0001356232,0.003025766,0.0002283293,0.001755107,0.0001789388,0.0000146064,0.00006437115],"genre_scores_gemma":[0.9944486,0.004036502,0.00006486624,0.001047977,0.0002170034,0.0001001708,0.000001199813,0.00002466366,0.00005903045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1225206,"threshold_uncertainty_score":0.5959839,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2595403257","doi":"10.1007/s00280-017-3260-6","title":"A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma","year":2017,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech","keywords":"Chills; Medicine; Carboplatin; Internal medicine; Melanoma; Nausea; Oncology; Adverse effect; Paclitaxel; Phases of clinical research; Chemotherapy; Immunotherapy; Gastroenterology; myalgia; Cancer; Immunology; Cisplatin; Cancer research","authors":[{"name":"Devalingam Mahalingam","is_ca":false},{"name":"Christos Fountzilas","is_ca":false},{"name":"Jennifer L. Moseley","is_ca":false},{"name":"Nicole Noronha","is_ca":true},{"name":"Hue Tran","is_ca":true},{"name":"Romit Chakrabarty","is_ca":true},{"name":"Giovanni Selvaggi","is_ca":true},{"name":"Matthew Coffey","is_ca":true},{"name":"Brad Thompson","is_ca":true},{"name":"John Sarantopoulos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01482268013146391,"gpt":0.3479693058060301,"spread":0.3331466256745662,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001442647,0.0001447514,0.0002242952,0.00005024563,0.000170648,0.00001140364,0.0001244108,0.00006706423,0.00001731716],"category_scores_gemma":[0.000006589249,0.0001135426,0.00001507633,0.00004114321,0.0001788131,0.0000108933,0.00004053387,0.00006739879,2.684691e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001626373,"about_ca_system_score_gemma":0.00006538527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005022791,"about_ca_topic_score_gemma":0.0004742706,"domain_scores_codex":[0.9991744,0.00005603585,0.0001495739,0.0003381128,0.00008769565,0.0001941855],"domain_scores_gemma":[0.9994228,0.00001743489,0.000168818,0.0002116486,0.0001234405,0.00005588333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06206559,0.003146901,0.07909346,0.00007797705,0.0003500168,0.000003822504,0.001167563,0.00002582358,0.7545081,0.000005795939,0.00006616395,0.09948881],"study_design_scores_gemma":[0.1109886,0.1274231,0.0271529,0.00003942432,0.00007076388,0.000001970167,0.0002335023,0.0002134143,0.7325177,0.00004605926,0.001002069,0.0003104257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997701,0.0007447204,0.00002696932,0.0001888447,0.00004132004,0.001226372,0.00004557969,0.000003141918,0.00002199765],"genre_scores_gemma":[0.9987243,0.0005457893,0.0001065043,0.0001558965,0.00003585258,0.0003279382,0.0000264817,0.00002365343,0.00005360479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1242762,"threshold_uncertainty_score":0.4630134,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973588440","doi":"10.1007/s00280-013-2224-8","title":"A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Panobinostat; Medicine; Prostate cancer; Tolerability; Internal medicine; Oncology; Cancer; Clinical endpoint; Prostate-specific antigen; Phases of clinical research; Urology; Adverse effect; Chemotherapy; Clinical trial; Histone deacetylase","authors":[{"name":"Dana E. Rathkopf","is_ca":false},{"name":"Joel Picus","is_ca":false},{"name":"Arif Hussain","is_ca":false},{"name":"Susan Ellard","is_ca":true},{"name":"Kim Nguyen","is_ca":true},{"name":"Thomas Nydam","is_ca":false},{"name":"E. Allen-Freda","is_ca":false},{"name":"Kaushal Mishra","is_ca":false},{"name":"Maria Grazia Porro","is_ca":false},{"name":"Howard I. Scher","is_ca":false},{"name":"George Wilding","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008602750773293795,"gpt":0.3132406636134182,"spread":0.3046379128401244,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006042746,0.0001397081,0.0001878246,0.00006188092,0.00004425427,0.000009202691,0.00008557704,0.00006582644,0.0003094713],"category_scores_gemma":[0.000002489408,0.0001175289,0.00001562228,0.0001212078,0.0001267468,0.000008338941,0.00002220561,0.0001091511,9.166966e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004495453,"about_ca_system_score_gemma":0.0001534148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001108064,"about_ca_topic_score_gemma":0.0005474536,"domain_scores_codex":[0.9990619,0.00007887097,0.0002073381,0.0002953999,0.0001152251,0.0002412184],"domain_scores_gemma":[0.9995598,0.0000100966,0.00008745772,0.0001114766,0.0001548232,0.00007635388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003075481,0.002342849,0.03302781,0.00005075385,0.0001466862,0.000004059601,0.002121785,0.00005460544,0.9385572,4.803585e-7,0.001556993,0.01906128],"study_design_scores_gemma":[0.03435476,0.008250311,0.03972652,0.0000254571,0.00003246389,0.000001352108,0.0004435044,0.000044458,0.913573,0.000004418517,0.003263433,0.0002803235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977581,0.0006647159,0.000002679798,0.0001696171,0.00008224276,0.001237611,0.00005231536,0.000004093728,0.00002866018],"genre_scores_gemma":[0.9984266,0.0005043217,0.00001666685,0.0002412475,0.00007358576,0.0005495962,0.00002539749,0.00002174503,0.0001408803],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03127928,"threshold_uncertainty_score":0.4792688,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996081258","doi":"10.1007/s00280-008-0730-x","title":"Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults","year":2008,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; Izaak Walton Killam Health Centre","funders":"","keywords":"Imatinib; Imatinib mesylate; Medicine; Pharmacokinetics; NONMEM; Tyrosine-kinase inhibitor; Pharmacology; Population; Myeloid leukemia; Internal medicine; Dosing; Metabolite; Oncology; Cancer","authors":[{"name":"Divya Menon-Andersen","is_ca":false},{"name":"John Mondick","is_ca":false},{"name":"Bhuvana Jayaraman","is_ca":false},{"name":"Patrick A. Thompson","is_ca":false},{"name":"Susan M. Blaney","is_ca":false},{"name":"Mark L. Bernstein","is_ca":true},{"name":"Mason Bond","is_ca":true},{"name":"Martin Champagne","is_ca":true},{"name":"Michael J. Fossler","is_ca":false},{"name":"Jeffrey S. Barrett","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01325244747741804,"gpt":0.3094661737160925,"spread":0.2962137262386745,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006436807,0.0001473595,0.0003556052,0.00008713787,0.00003627881,0.000001977458,0.00002745644,0.00007579589,0.0001965179],"category_scores_gemma":[0.000003826494,0.0001327518,0.00002123978,0.0001048484,0.00008748236,0.00006008479,0.00001850563,0.0001249169,3.819279e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006782956,"about_ca_system_score_gemma":0.00005105337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003577214,"about_ca_topic_score_gemma":0.000008901336,"domain_scores_codex":[0.9992447,0.00003702233,0.0002270084,0.000240612,0.00007634031,0.0001742783],"domain_scores_gemma":[0.9996983,0.00002596359,0.00009591506,0.00005456035,0.00003392827,0.00009134495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001341229,0.0001227596,0.860447,0.0001842287,0.0003533863,0.00001585626,0.001787607,0.000007717843,0.1002232,0.00001434997,0.0001897555,0.03531288],"study_design_scores_gemma":[0.01907549,0.0001248472,0.8705437,0.00004265876,0.000169985,0.0002478769,0.000008660484,0.001561569,0.1077884,0.00001674844,0.0003039167,0.0001160695],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701421,0.02881793,0.00000150766,0.0003141288,0.000105574,0.0005133247,0.00003551532,0.00001431544,0.00005562927],"genre_scores_gemma":[0.9160732,0.08291505,0.0001215494,0.0006059517,0.0001136037,0.00003307601,0.00002594462,0.00001692365,0.00009469658],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05409712,"threshold_uncertainty_score":0.5413463,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996145189","doi":"10.1007/s00280-008-0704-z","title":"Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol","year":2008,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Acadia University; University of Alberta","funders":"","keywords":"Resveratrol; Cell cycle; Chemistry; Apoptosis; Tubulin; Cell cycle checkpoint; Cell culture; Viability assay; Western blot; MTT assay; Cell growth; Cell; Microtubule; Biochemistry; Cancer research; Biology; Cell biology; Gene; Genetics","authors":[{"name":"Zengshuan Ma","is_ca":true},{"name":"Ommoleila Molavi","is_ca":true},{"name":"Azita Haddadi","is_ca":true},{"name":"Raymond Lai","is_ca":true},{"name":"Robert A. Gossage","is_ca":true},{"name":"Afsaneh Lavasanifar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01952260389509793,"gpt":0.302641283421494,"spread":0.2831186795263961,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002117427,0.0004909461,0.001366028,0.0002225897,0.0001848948,0.000008049728,0.0001942405,0.0002999268,0.001957177],"category_scores_gemma":[0.0000173717,0.0003616722,0.0002481521,0.0002414317,0.0005026094,0.00007743484,0.00002951004,0.0006058686,0.000002576058],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008924249,"about_ca_system_score_gemma":0.0001596885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002977762,"about_ca_topic_score_gemma":0.00001557593,"domain_scores_codex":[0.9975975,0.0002365458,0.0005235235,0.0006600296,0.0004214231,0.0005609408],"domain_scores_gemma":[0.9983753,0.0005367739,0.0002393075,0.0003122134,0.0001252272,0.0004111691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002287459,0.0004084659,0.02424265,0.0003236579,0.001348646,0.0003667639,0.001179932,0.00001123297,0.9619311,0.00002401209,0.002638211,0.005237887],"study_design_scores_gemma":[0.01755063,0.001326991,0.04881686,0.0001739824,0.0009848877,0.0001522187,0.00005235632,0.001559706,0.9263748,0.0003887292,0.002263726,0.0003551315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767976,0.01529874,0.002202246,0.002821622,0.00167023,0.0009350515,0.0000944444,0.00008077949,0.00009922182],"genre_scores_gemma":[0.9628189,0.02686707,0.0004505011,0.008075214,0.001380921,0.0001350757,0.00004995281,0.0000714101,0.0001509822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03555631,"threshold_uncertainty_score":0.9998835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992550766","doi":"10.1007/s00280-013-2226-6","title":"Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells","year":2013,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institutes of Health; Public Health Agency of Canada","keywords":"Gemcitabine; Pharmacodynamics; Apoptosis; Adenocarcinoma; Pancreatic cancer; Cell cycle; Cancer research; Internal medicine; Pharmacology; Chemistry; Oncology; Medicine; Biology; Chemotherapy; Pharmacokinetics; Cancer; Biochemistry","authors":[{"name":"Salaheldin S. Hamed","is_ca":false},{"name":"Robert M. Straubinger","is_ca":false},{"name":"William J. Jusko","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01317331133255819,"gpt":0.3144601849627526,"spread":0.3012868736301945,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001216032,0.0001753765,0.0006631188,0.0001233725,0.00004249308,0.000003184568,0.00007110176,0.0001172496,0.0009543039],"category_scores_gemma":[0.00000724886,0.0001445443,0.00005236453,0.0001114285,0.0002545977,0.00004458494,0.00002684411,0.0002125075,0.000005201318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004490578,"about_ca_system_score_gemma":0.0001031569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001887678,"about_ca_topic_score_gemma":7.924603e-7,"domain_scores_codex":[0.9989473,0.00009057948,0.0002905667,0.0002593142,0.0001282769,0.0002839809],"domain_scores_gemma":[0.9991655,0.0003377272,0.0001099193,0.0001183896,0.0000968958,0.0001715782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007015475,0.0003015098,0.01820179,0.002065148,0.0002953338,0.000008244999,0.0006195622,0.0001036325,0.9740208,0.00001317466,0.0002722791,0.003397007],"study_design_scores_gemma":[0.01129902,0.001458022,0.01864275,0.0001796165,0.0006008325,0.00001386082,0.00008005612,0.1664838,0.8008283,0.0002106682,0.00003759725,0.0001655052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918343,0.005544907,0.0001600197,0.0005047681,0.0001394762,0.0009440944,0.000006492254,0.00001433076,0.0008515774],"genre_scores_gemma":[0.9870005,0.0109036,0.000381266,0.001069581,0.0001056753,0.0001422761,0.00000261014,0.00002494321,0.0003696124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1731925,"threshold_uncertainty_score":0.9999589,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017908039","doi":"10.1007/s00280-013-2176-z","title":"Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues","year":2013,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Topotecan; Mitoxantrone; Doxorubicin; Pharmacology; Medicine; Distribution (mathematics); Anticancer drug; Chemotherapy; Drug; Cancer research; Internal medicine","authors":[{"name":"Krupa Patel","is_ca":true},{"name":"Olivier Trédan","is_ca":false},{"name":"Ian F. Tannock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005373125667298539,"gpt":0.2637172799360422,"spread":0.2583441542687437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007527759,0.0001109533,0.0001540225,0.00001622161,0.00004977007,0.000009521475,0.00006978653,0.00008338394,0.0001030705],"category_scores_gemma":[0.00000170239,0.00008805541,0.00002129576,0.0000580242,0.0002185249,0.000006157413,0.0000535942,0.00008085974,1.54786e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000143983,"about_ca_system_score_gemma":0.00004157624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003676138,"about_ca_topic_score_gemma":0.00006884333,"domain_scores_codex":[0.9993906,0.00003583367,0.0001371942,0.0002100554,0.00004988459,0.0001764012],"domain_scores_gemma":[0.9997571,0.00001039099,0.00006436428,0.00008458957,0.00003359683,0.00004992189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001184557,0.00002447117,0.003866632,0.00003605322,0.00004444509,2.38263e-7,0.0002703414,0.000004413094,0.9431092,0.000109903,0.0004554672,0.05196035],"study_design_scores_gemma":[0.001682295,0.0001428624,0.0224294,0.00001903616,0.00002338311,0.000006461629,0.00009784398,0.0001260853,0.9507402,0.0003193695,0.02428728,0.0001258089],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886392,0.008842516,0.00005682271,0.00193997,0.0001744069,0.0002645356,0.00002920689,0.000002933259,0.00005038732],"genre_scores_gemma":[0.9838212,0.01416155,0.00002532812,0.001632466,0.0001462099,0.0000595104,0.000007463898,0.00001055852,0.0001357258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05183454,"threshold_uncertainty_score":0.3590795,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2061780793","doi":"10.1007/s00280-007-0449-0","title":"Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model","year":2007,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":72,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Paclitaxel; Ovarian cancer; Tolerability; Medicine; Drug delivery; Drug; Biocompatible material; Pharmacology; Intraperitoneal chemotherapy; Chemotherapy; Oncology; Cancer; Internal medicine; Adverse effect; Chemistry; Biomedical engineering","authors":[{"name":"Vessela Vassileva","is_ca":true},{"name":"Justin Grant","is_ca":true},{"name":"Raquel De Souza","is_ca":true},{"name":"Christine Allen","is_ca":true},{"name":"Micheline Piquette‐Miller","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02333756305921233,"gpt":0.3146053325226493,"spread":0.291267769463437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008965385,0.0002540203,0.000523968,0.000148255,0.0001343731,0.00002474501,0.0001915672,0.0001141095,0.0002424594],"category_scores_gemma":[0.000003621288,0.0002387213,0.00005088217,0.0002545503,0.000473782,0.0001320239,0.00005628834,0.0001679734,8.163558e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002139306,"about_ca_system_score_gemma":0.0001860837,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006681416,"about_ca_topic_score_gemma":0.0008900568,"domain_scores_codex":[0.9981117,0.0001324471,0.0005696334,0.0005069484,0.0001616423,0.0005175784],"domain_scores_gemma":[0.9990691,0.0002711794,0.0002016553,0.0001830765,0.0000959858,0.0001789918],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001282146,0.0005239659,0.0129415,0.0002726834,0.00005071576,0.000005000983,0.001576773,0.0009016892,0.9751334,0.0001339658,0.000041643,0.007136483],"study_design_scores_gemma":[0.005967554,0.0001072112,0.01536914,0.0001065902,0.00007442421,0.000007070269,0.0002274076,0.01097003,0.9667337,0.00007424903,0.00008502289,0.0002776202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932277,0.005167582,0.0003058843,0.000287289,0.0002284511,0.0005869565,0.0001055565,0.00006223965,0.00002839515],"genre_scores_gemma":[0.997734,0.0004668098,0.0005320208,0.0009740388,0.0001452533,0.0001070827,0.000002729337,0.00002712602,0.00001090466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01006834,"threshold_uncertainty_score":0.9999332,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020714490","doi":"10.1007/s00280-010-1410-1","title":"A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Howard Hughes Medical Institute; Sidney Kimmel Comprehensive Cancer Center; National Center for Research Resources; Alvin J. Siteman Cancer Center; Johns Hopkins University","keywords":"Irinotecan; Medicine; Pharmacokinetics; Pharmacodynamics; Internal medicine; Gastroenterology; Pharmacology; Urology; Colorectal cancer; Cancer","authors":[{"name":"Paula M. Fracasso","is_ca":false},{"name":"Kerry J. Williams","is_ca":false},{"name":"Ronald C. Chen","is_ca":false},{"name":"Joel Picus","is_ca":false},{"name":"X. Cynthia","is_ca":false},{"name":"Matthew J. Ellis","is_ca":false},{"name":"Benjamin Tan","is_ca":false},{"name":"Timothy Pluard","is_ca":false},{"name":"Douglas R. Adkins","is_ca":false},{"name":"Michael Naughton","is_ca":false},{"name":"Janet S. Rader","is_ca":false},{"name":"Matthew A. Arquette","is_ca":false},{"name":"James W. Fleshman","is_ca":false},{"name":"Allison Creekmore","is_ca":false},{"name":"Sherry A. Goodner","is_ca":false},{"name":"L. Wright","is_ca":false},{"name":"Zhanfang Guo","is_ca":false},{"name":"Christine E. Ryan","is_ca":false},{"name":"Tao Yu","is_ca":false},{"name":"Eliane Maria Azevedo Soares","is_ca":false},{"name":"Shi-Rong Cai","is_ca":false},{"name":"Lin Li","is_ca":false},{"name":"Janet Dancey","is_ca":true},{"name":"Michelle A. Rudek","is_ca":false},{"name":"Howard L. McLeod","is_ca":false},{"name":"Helen Piwnica‐Worms","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008558402501655257,"gpt":0.2960906309517816,"spread":0.2875322284501263,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009540615,0.0001340587,0.0001962898,0.00007149702,0.00002695782,0.000005690259,0.00008743886,0.00005957251,0.0000538872],"category_scores_gemma":[0.000001097461,0.0001091739,0.00001258347,0.0001204901,0.00008302246,0.000005059146,0.00001770709,0.000124693,6.6441e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001837242,"about_ca_system_score_gemma":0.00008945196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001445571,"about_ca_topic_score_gemma":0.002181013,"domain_scores_codex":[0.9992753,0.00003413251,0.0001675931,0.0002606762,0.00008168695,0.0001805823],"domain_scores_gemma":[0.9996666,0.000006657042,0.0001035848,0.0001165061,0.00006523902,0.00004144579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007044144,0.002974892,0.02587993,0.00002873734,0.00007688352,0.000004990529,0.0007718176,0.00001935517,0.9575663,0.00002266125,0.00002389959,0.005586345],"study_design_scores_gemma":[0.04899628,0.01268642,0.04122927,0.0000256837,0.00003659226,0.000001875634,0.0002709686,0.00004811273,0.8938621,0.0000436672,0.002554131,0.0002449022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990065,0.0001360364,0.00002652522,0.00009745232,0.0001180051,0.0005632493,0.00001849717,0.000003589945,0.00003011615],"genre_scores_gemma":[0.9990645,0.000128522,0.0000555079,0.0005241321,0.00003990131,0.0001297219,0.00001202085,0.00001972845,0.00002594254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06370426,"threshold_uncertainty_score":0.4451983,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995389617","doi":"10.1007/s00280-002-0443-5","title":"Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study","year":2002,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institute on Aging","keywords":"Fludarabine; Medicine; Toxicity; Creatinine; Internal medicine; Renal function; Gastroenterology; Chronic lymphocytic leukemia; Anemia; Neutropenia; Clinical endpoint; Interquartile range; Leukemia; Surgery; Cyclophosphamide; Chemotherapy; Clinical trial","authors":[{"name":"Robert E. Martell","is_ca":false},{"name":"Bercedis L. Peterson","is_ca":false},{"name":"William P. Petros","is_ca":false},{"name":"Vicki A. Morrison","is_ca":false},{"name":"Laurence Elias","is_ca":false},{"name":"Lois E. Shepherd","is_ca":true},{"name":"John Hines","is_ca":false},{"name":"Richard A. Larson","is_ca":false},{"name":"Charles A. Schiffer","is_ca":false},{"name":"Herbert I. Hurwitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03070062146814773,"gpt":0.3453199439162757,"spread":0.314619322448128,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001829138,0.0002924316,0.001246734,0.0004165463,0.00004278144,0.000006358735,0.0001137181,0.0001778322,0.0004580115],"category_scores_gemma":[0.00005875039,0.0002408682,0.0001164326,0.0009529841,0.0004146278,0.00005255322,0.00004396922,0.0001435322,5.524006e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01112357,"about_ca_system_score_gemma":0.0008504903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002237302,"about_ca_topic_score_gemma":0.0001549393,"domain_scores_codex":[0.9981207,0.0001294644,0.0006307546,0.0005280233,0.00019539,0.0003956398],"domain_scores_gemma":[0.998898,0.0003132604,0.0002569836,0.0002175351,0.0001595652,0.0001546643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0219436,0.003133655,0.913133,0.001682738,0.01350459,0.0001576005,0.005260692,0.003989515,0.02388582,0.0000044554,0.0005750749,0.0127293],"study_design_scores_gemma":[0.1751606,0.01528149,0.204478,0.0003297541,0.004791212,0.00002225296,0.0001658733,0.4578321,0.1415045,0.000009578984,0.00003946117,0.0003852007],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949856,0.002481299,0.00001365291,0.00005326027,0.00006302207,0.002262051,0.00006524308,0.00003356686,0.00004225567],"genre_scores_gemma":[0.996933,0.002188321,0.000061254,0.0001620426,0.00001715751,0.0004001979,0.00004762402,0.00002866415,0.0001617839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.708655,"threshold_uncertainty_score":0.9926726,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2038893680","doi":"10.1007/s00280-009-1096-4","title":"UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Sorafenib; Hepatocellular carcinoma; Medicine; Bilirubin; Unconjugated hyperbilirubinemia; Internal medicine; Gastroenterology; Cirrhosis; Glucuronosyltransferase; Doxorubicin; Pharmacology; Chemotherapy; Chemistry; Biochemistry; Microsome","authors":[{"name":"Judith Meza–Junco","is_ca":true},{"name":"Quincy S. Chu","is_ca":true},{"name":"Olaf Christensen","is_ca":false},{"name":"Prabhu Rajagopalan","is_ca":false},{"name":"Soma Das","is_ca":false},{"name":"Ruslan Stefanyschyn","is_ca":true},{"name":"Michael B. Sawyer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01097326980190678,"gpt":0.3202515898681827,"spread":0.3092783200662759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005537364,0.0001304431,0.0002542172,0.00004546285,0.00004245811,0.00000376226,0.00003115051,0.0001235806,0.0004250597],"category_scores_gemma":[0.00000330949,0.0001121247,0.00002208396,0.00009842437,0.00008933335,0.00002709547,0.000008566733,0.0002094872,0.000001009188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006051308,"about_ca_system_score_gemma":0.000103387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007712391,"about_ca_topic_score_gemma":0.000005773997,"domain_scores_codex":[0.9992369,0.00001900382,0.0001735719,0.0002578094,0.00006062112,0.0002520733],"domain_scores_gemma":[0.9996417,0.00002546522,0.00004463006,0.00006809749,0.00002293798,0.0001971959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002192255,0.0001208911,0.004004469,0.0001546384,0.00001971323,0.00007389464,0.0007590736,3.388208e-7,0.6130951,0.000004930804,0.00333547,0.3762392],"study_design_scores_gemma":[0.01414878,0.001149733,0.03284549,0.0001731412,0.00005576728,0.0002855255,0.0001704604,0.0002301202,0.8938954,0.0002771708,0.05644787,0.0003205606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683991,0.01518364,0.000001037745,0.01527717,0.0001255547,0.000291481,0.000008849433,0.00002062274,0.0006925167],"genre_scores_gemma":[0.9574042,0.01103188,0.00007420215,0.03081584,0.0002220042,0.00002950424,0.000006186287,0.000008976519,0.0004071979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3759187,"threshold_uncertainty_score":0.4654106,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2042603355","doi":"10.1007/s00280-013-2155-4","title":"Bevacizumab and central nervous system (CNS) hemorrhage","year":2013,"lang":"en","type":"review","venue":"Cancer Chemotherapy and Pharmacology","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Bevacizumab; Central nervous system; Medicine; Neuroscience; Chemotherapy; Internal medicine; Biology","authors":[{"name":"Nathalie Letarte","is_ca":true},{"name":"Linda R. Bressler","is_ca":false},{"name":"John L. Villano","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06067157245023656,"gpt":0.3763465730440886,"spread":0.3156750005938521,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005063804,0.0003576961,0.001438188,0.00008296306,0.0001010389,0.00002344677,0.0001114249,0.0002997918,0.00129681],"category_scores_gemma":[0.000002395545,0.0002481017,0.0001579215,0.0001275063,0.0001599271,0.00003078842,0.00004571927,0.0004251988,0.00001995572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009548028,"about_ca_system_score_gemma":0.0001225676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001965396,"about_ca_topic_score_gemma":4.602549e-7,"domain_scores_codex":[0.9986019,0.0001083926,0.0003549157,0.0005017897,0.0000763483,0.0003566309],"domain_scores_gemma":[0.9992408,0.0001046977,0.0001693832,0.0001840325,0.00003833189,0.0002627146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003684134,0.00004260761,0.00001553624,0.01564304,0.0002159206,0.00007212009,0.00002672213,6.273037e-8,0.000132209,0.00006642975,0.002596126,0.9811524],"study_design_scores_gemma":[0.001056638,0.0001977427,0.00009921744,0.0005656007,0.001044153,0.001754643,0.000006661651,0.00007134873,0.00003867862,0.00001111931,0.994928,0.0002262231],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00429965,0.9925817,0.00001495528,0.000673383,0.0004051622,0.001312434,0.00004457045,0.00008359071,0.0005845712],"genre_scores_gemma":[0.001416094,0.9945381,0.0001090886,0.001848127,0.0004885664,0.0005554289,0.00002722739,0.00004680984,0.0009705027],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9923319,"threshold_uncertainty_score":0.9999971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976238224","doi":"10.1007/s00280-004-0817-y","title":"Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis","year":2004,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Brock University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Apoptosis; In vivo; In vitro; Camptothecin; DAPI; Mammary tumor; Molecular biology; Chemistry; Pharmacology; Transfection; Biochemistry; Biology; Medicine; Internal medicine","authors":[{"name":"Karla A. Lawson","is_ca":false},{"name":"K. C. Anderson","is_ca":false},{"name":"Rachel M. Snyder","is_ca":false},{"name":"Marla Simmons-Menchaca","is_ca":false},{"name":"Jeffrey Atkinson","is_ca":true},{"name":"Lu‐Zhe Sun","is_ca":false},{"name":"Abhik Bandyopadhyay","is_ca":false},{"name":"Vernon Knight","is_ca":false},{"name":"Brian E. Gilbert","is_ca":false},{"name":"Bob G. Sanders","is_ca":false},{"name":"Kimberly A. Kline","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01531023479892969,"gpt":0.2888894467009151,"spread":0.2735792119019854,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001404753,0.0003312847,0.0003459777,0.00007513457,0.0001385153,0.00005380018,0.0001508629,0.0001729582,0.0001196692],"category_scores_gemma":[0.000007098056,0.000325015,0.00006765102,0.00009327158,0.0002078069,0.00001561073,0.0001180508,0.0001450572,0.000001391348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000403023,"about_ca_system_score_gemma":0.0002769775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002185346,"about_ca_topic_score_gemma":0.00009039864,"domain_scores_codex":[0.998606,0.0000461151,0.000243773,0.0006336903,0.0000931223,0.0003773018],"domain_scores_gemma":[0.99923,0.00001984086,0.0001216823,0.0002128632,0.00005799912,0.0003576009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006808893,0.00007794192,0.00007038534,0.0000640596,0.0003764755,0.0000143868,0.0002087355,0.00001117897,0.9824673,0.0002511303,0.0001283983,0.01564913],"study_design_scores_gemma":[0.006658679,0.0007144705,0.0001041332,0.00002157525,0.0001469197,0.0002164226,0.00007062603,0.00002751571,0.9466562,0.0004034197,0.04458647,0.000393525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833917,0.01208797,0.001308307,0.002307238,0.000198233,0.0004322729,0.0001768307,0.00002253144,0.00007491633],"genre_scores_gemma":[0.9638767,0.02173414,0.001236548,0.01192856,0.0005351148,0.0001769267,0.0000554627,0.00006085242,0.0003956598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04445807,"threshold_uncertainty_score":0.9999202,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140095109","doi":"10.1007/s00280-004-0949-0","title":"A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Vector Institute","keywords":"Gemcitabine; Conjugate; Deoxycytidine kinase; Nucleoside transporter; Pharmacology; Phospholipid; Nucleoside; Antimetabolite; Chemistry; Cancer research; Deoxycytidine; Biology; Chemotherapy; Biochemistry; Medicine; Internal medicine; Transporter","authors":[{"name":"Richard Alexander","is_ca":false},{"name":"Bryan T. Greene","is_ca":false},{"name":"Suzy V. Torti","is_ca":false},{"name":"Gregory L. Kucera","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01329631680810485,"gpt":0.2922853730567955,"spread":0.2789890562486907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001852089,0.0003383425,0.0005631149,0.000099502,0.0001581269,0.00001843115,0.0001680385,0.0001462689,0.005379166],"category_scores_gemma":[0.000001727002,0.0002985172,0.0001143508,0.0002695712,0.0001099291,0.00009481916,0.00002182534,0.0002608018,0.00004510107],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001334462,"about_ca_system_score_gemma":0.0001444447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005150779,"about_ca_topic_score_gemma":0.0004269213,"domain_scores_codex":[0.9982494,0.00001225725,0.0003378848,0.0005853767,0.0002242655,0.0005908754],"domain_scores_gemma":[0.9991396,0.00002576716,0.00009612898,0.0002277852,0.0001186325,0.0003920804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002649179,0.0002797867,0.0001859652,0.0001932194,0.0003330924,0.0000194182,0.001216653,0.00001964352,0.9453785,0.001393517,0.03725095,0.01108011],"study_design_scores_gemma":[0.006095652,0.00007425228,0.0003926414,0.0000669268,0.000147802,0.00001149707,0.00003290721,0.0001778071,0.5926939,0.0003886491,0.3996511,0.0002668352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7794696,0.01466131,0.05023705,0.1441098,0.002608864,0.002691565,0.0002637992,0.0003723414,0.005585692],"genre_scores_gemma":[0.7622626,0.005889792,0.0282677,0.1531336,0.001799238,0.0006159837,0.00002743871,0.0001667169,0.04783696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3624002,"threshold_uncertainty_score":0.9999467,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015268376","doi":"10.1007/s00280-011-1679-8","title":"Hematologic adverse events associated with temozolomide","year":2011,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Pancytopenia; Medicine; Aplastic anemia; Internal medicine; Adverse effect; Myelodysplastic syndromes; Temozolomide; Bone marrow suppression; Bone marrow failure; Bone Marrow Aplasia; Pediatrics; Surgery; Bone marrow; Chemotherapy","authors":[{"name":"John L. Villano","is_ca":false},{"name":"Nathalie Letarte","is_ca":true},{"name":"Janny ManYan Yu","is_ca":false},{"name":"Linda R. Bressler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04505727237691332,"gpt":0.3367991244967081,"spread":0.2917418521197948,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001475893,0.0001596817,0.0003252629,0.00007200646,0.00006914709,0.000001140275,0.0000912407,0.0001421746,0.004272687],"category_scores_gemma":[0.00001185444,0.0001159317,0.0000407193,0.0001788651,0.0002033565,0.00005269919,0.00002496609,0.000294448,0.00001658607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002019724,"about_ca_system_score_gemma":0.0002253546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006589649,"about_ca_topic_score_gemma":0.00001288503,"domain_scores_codex":[0.9990463,0.00006731513,0.0001448583,0.0002775349,0.0001123094,0.0003516834],"domain_scores_gemma":[0.9994866,0.0000633357,0.00007814155,0.0001087649,0.00008506885,0.0001780528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01598393,0.001184235,0.6831054,0.0003239866,0.003527963,0.0009526442,0.004690791,0.000004272806,0.2374114,0.0001631038,0.03670296,0.01594931],"study_design_scores_gemma":[0.04256006,0.002463751,0.2502774,0.0002097431,0.0006864476,0.0005221269,0.0003752033,0.0006545059,0.6783331,0.0005569374,0.02264106,0.0007196807],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939743,0.0005966411,0.00004090991,0.001530273,0.0001278639,0.0004626459,0.000009140301,0.00007549059,0.003182769],"genre_scores_gemma":[0.9882115,0.001607652,0.0003321323,0.007707133,0.0001039346,0.0001295887,0.000009264375,0.00003092448,0.001867901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4409217,"threshold_uncertainty_score":0.9966375,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094417916","doi":"10.1007/s00280-010-1379-9","title":"Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary; McGill University; Dr. H. Bliss Murphy Cancer Centre; Saskatchewan Cancer Agency; Aptose Biosciences (Canada); Alberta Cancer Foundation","funders":"","keywords":"Medicine; Nimotuzumab; Chills; Rash; Toxicity; Internal medicine; Lung cancer; Regimen; Oncology; Gastroenterology; Radiation therapy; Phases of clinical research; Surgery; Cancer; Epidermal growth factor receptor","authors":[{"name":"Gwyn Bebb","is_ca":true},{"name":"Colum J Smith","is_ca":true},{"name":"Stewart Rorke","is_ca":true},{"name":"William K Boland","is_ca":true},{"name":"Leonardo Nicacio","is_ca":true},{"name":"Ryan Sukhoo","is_ca":true},{"name":"Anthony Brade","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03060500181438004,"gpt":0.4110274883242362,"spread":0.3804224865098562,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005722092,0.0004539246,0.0009625147,0.0001708785,0.0001912642,0.00003045611,0.0003223936,0.0003237559,0.002086994],"category_scores_gemma":[0.00000891935,0.0002666938,0.0002069844,0.0003893075,0.0006570937,0.0001014383,0.00001616948,0.0007328151,2.129812e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003126558,"about_ca_system_score_gemma":0.003589873,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02209356,"about_ca_topic_score_gemma":0.03269015,"domain_scores_codex":[0.9973851,0.0001562224,0.0007411361,0.0006506059,0.0002794172,0.0007875506],"domain_scores_gemma":[0.998339,0.0003121838,0.0004618233,0.00028488,0.0001941537,0.0004079335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4452667,0.004044638,0.2774375,0.0003356031,0.001070978,0.00004286729,0.00125724,0.00001776973,0.13941,0.00000358877,0.002184685,0.1289283],"study_design_scores_gemma":[0.7137001,0.0117514,0.05131566,0.0004455787,0.0003285118,0.00001827954,0.0000776342,0.002506786,0.115782,0.000002051365,0.1034044,0.0006677278],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870829,0.004047579,0.0002044659,0.001140482,0.001814315,0.0051257,0.0005294366,0.00001844699,0.00003667663],"genre_scores_gemma":[0.9742936,0.01774846,0.0002878909,0.005293462,0.0008977593,0.0009695238,0.00006145357,0.00009145035,0.0003564034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2684333,"threshold_uncertainty_score":0.9999785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106673894","doi":"10.1007/s00280-004-0914-y","title":"Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Institut National de la Santé et de la Recherche Médicale","keywords":"Rhodamine 123; P-glycoprotein; Vinca; Vinblastine; Pharmacology; ATP-binding cassette transporter; Multiple drug resistance; Cell culture; Cytotoxicity; Verapamil; In vitro; Biology; Vinca alkaloid; Umbelliferone; Doxorubicin; Chemistry; Vincristine; Biochemistry; Transporter; Coumarin; Chemotherapy","authors":[{"name":"Chantal Barthomeuf","is_ca":false},{"name":"Jérôme Grassi","is_ca":true},{"name":"Michel Demeule","is_ca":true},{"name":"Chantal Fournier","is_ca":true},{"name":"Dominique Boivin","is_ca":true},{"name":"Richard Béliveau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007670302057908099,"gpt":0.2630383083437881,"spread":0.25536800628588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001217664,0.0001195589,0.0003018697,0.0000566281,0.00003779521,8.924802e-7,0.00002300649,0.0001121197,0.0005808241],"category_scores_gemma":[7.571648e-7,0.0001069828,0.0000471168,0.00009863766,0.0001542078,0.00006794494,0.000002428616,0.0001110069,3.759075e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002962108,"about_ca_system_score_gemma":0.00003931863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002849996,"about_ca_topic_score_gemma":0.00004111746,"domain_scores_codex":[0.9992857,0.00001826056,0.0002519521,0.0002077806,0.0001036001,0.0001326895],"domain_scores_gemma":[0.9996656,0.00001532313,0.0001233756,0.0000664731,0.00005504919,0.00007414228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003481149,0.0001358547,0.002244147,0.0005103559,0.00007475032,0.000002426342,0.0005027787,0.000002722382,0.9808194,0.00004710416,0.002354234,0.009825088],"study_design_scores_gemma":[0.00573995,0.0001728264,0.005101293,0.0001556339,0.0001511574,0.000002263758,0.00006346634,0.00003341239,0.9510794,0.0001002872,0.03730027,0.0001000477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883221,0.008079755,0.0006731765,0.002023651,0.0001209489,0.0003829095,0.00005155465,0.00001615163,0.0003297976],"genre_scores_gemma":[0.9872144,0.0094069,0.000565438,0.0009150653,0.0001107319,0.00002898836,0.00002592755,0.00001526131,0.001717317],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03494603,"threshold_uncertainty_score":0.6359617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040193157","doi":"10.1007/s00280-008-0750-6","title":"Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine","year":2008,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Cancer Research Society","keywords":"Cytidine deaminase; Deoxycytidine; Cytidine; Deamination; Deoxycytidine kinase; Molecular biology; Adenosine deaminase; Chemistry; Biology; Biochemistry; Enzyme; Chemotherapy; Gemcitabine","authors":[{"name":"Maryse Lemaire","is_ca":true},{"name":"Louise F. Momparler","is_ca":true},{"name":"Noël J.‐M. Raynal","is_ca":true},{"name":"Mark L. Bernstein","is_ca":false},{"name":"Richard L. Momparler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01708839857140353,"gpt":0.3026246787053595,"spread":0.2855362801339559,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001074694,0.000106699,0.0001563311,0.00002732494,0.00006744298,0.000001744827,0.00005793083,0.00009128512,0.00009640478],"category_scores_gemma":[0.000009831406,0.00008437678,0.00004213335,0.00008677951,0.0002172951,0.000004359191,0.0000219769,0.00006257431,2.793394e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007129827,"about_ca_system_score_gemma":0.00004762422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004511657,"about_ca_topic_score_gemma":0.00001230617,"domain_scores_codex":[0.9993782,0.00005330642,0.0002068138,0.0001755106,0.00006997369,0.0001161731],"domain_scores_gemma":[0.9995821,0.00003233765,0.0001749641,0.00009108686,0.00008633185,0.00003318251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002935752,0.00007092609,0.001959894,0.00004557244,0.00006314797,5.183073e-7,0.00009688049,0.00005714343,0.9919983,0.000006065258,0.0008965437,0.004511483],"study_design_scores_gemma":[0.001138529,0.0003278104,0.001872373,0.000007926658,0.00003003901,0.000004681896,0.00001629236,0.0001042809,0.9867688,0.00004367419,0.009601369,0.00008422365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904562,0.007357542,0.001437687,0.0003234824,0.0001733827,0.0001493222,0.00003191861,0.000004001228,0.00006651587],"genre_scores_gemma":[0.9608204,0.03848217,0.00008122467,0.0001763199,0.0002033613,0.00002298014,0.00004737588,0.00001165555,0.0001544987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03112463,"threshold_uncertainty_score":0.3440785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006140059","doi":"10.1007/s00280-020-04038-8","title":"Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nexen (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Tolerability; Trametinib; Dosing; Medicine; Rash; Adverse effect; Internal medicine; Mucositis; Oncology; Pharmacology; Toxicity; MAPK/ERK pathway","authors":[{"name":"Anthony W. Tolcher","is_ca":true},{"name":"Razelle Kurzrock","is_ca":false},{"name":"V. Valero","is_ca":false},{"name":"René González","is_ca":false},{"name":"Rebecca S. Heist","is_ca":false},{"name":"Antoinette R. Tan","is_ca":false},{"name":"Julie Means‐Powell","is_ca":false},{"name":"Theresa L. Werner","is_ca":false},{"name":"Carlos Becerra","is_ca":false},{"name":"Chenxi Wang","is_ca":false},{"name":"Cathrine Leonowens","is_ca":false},{"name":"Shanker Kalyana‐Sundaram","is_ca":false},{"name":"Joseph F. Kleha","is_ca":false},{"name":"Jennifer Gauvin","is_ca":false},{"name":"Anthony M. D’Amelio","is_ca":false},{"name":"Catherine Ellis","is_ca":false},{"name":"Nageatte Ibrahim","is_ca":false},{"name":"Yan Li","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01414950799063345,"gpt":0.2872376165837309,"spread":0.2730881085930975,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001425458,0.0001568055,0.0002286441,0.00002709196,0.00004894675,0.00000937748,0.0001286052,0.0001056748,0.00003327586],"category_scores_gemma":[0.000008493539,0.00009154955,0.00003480144,0.0001961993,0.0001636395,0.00001083293,0.00002798735,0.0001605985,2.259684e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002077759,"about_ca_system_score_gemma":0.0001207346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000271517,"about_ca_topic_score_gemma":0.00009152128,"domain_scores_codex":[0.9990327,0.0001587118,0.0002366347,0.0002692028,0.0001195957,0.00018314],"domain_scores_gemma":[0.9996101,0.00001744894,0.0001627352,0.0001000051,0.00005783509,0.00005186294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1118161,0.001647779,0.03807384,0.00007640244,0.0001106344,0.000002707877,0.001770838,0.0001495272,0.8273017,0.00002254116,0.001439004,0.01758893],"study_design_scores_gemma":[0.1534005,0.006319862,0.01441906,0.00002631186,0.00003701599,8.584262e-7,0.00007982578,0.0002649537,0.8214734,0.0000143938,0.003773056,0.0001908296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965128,0.0001082187,0.00003810677,0.002044919,0.0001965178,0.001037217,0.00002338437,0.000005137809,0.00003372861],"genre_scores_gemma":[0.9977234,0.00004595072,0.00002903593,0.001808381,0.0002020189,0.0001175005,0.00003499031,0.00001871661,0.00001999853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04158439,"threshold_uncertainty_score":0.3733282,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975048166","doi":"10.1007/s00280-005-0077-5","title":"A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Medicine; Pharmacodynamics; Neutropenia; Population; Pharmacology; Pharmacokinetics; Homocysteine; Internal medicine; Oncology; Chemotherapy","authors":[{"name":"Jane E. Latz","is_ca":false},{"name":"Mats O. Karlsson","is_ca":false},{"name":"James J. Rusthoven","is_ca":true},{"name":"Atalanta Ghosh","is_ca":false},{"name":"Robert D. Johnson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03385451318269302,"gpt":0.3721025579256311,"spread":0.3382480447429381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001327486,0.0003083029,0.0004791639,0.0001261694,0.0002457991,0.00002096539,0.0001099317,0.0001263292,0.001096628],"category_scores_gemma":[0.00000309689,0.0002719117,0.0002243743,0.0001993057,0.00005688686,0.0001426967,0.00002160413,0.0002417763,0.000005927854],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001869473,"about_ca_system_score_gemma":0.000106176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003335746,"about_ca_topic_score_gemma":0.00001020664,"domain_scores_codex":[0.998579,0.00004802955,0.0003127119,0.0004995918,0.000120126,0.0004405091],"domain_scores_gemma":[0.9993966,0.00007216818,0.0001244023,0.0001335562,0.00008384596,0.0001894269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002192662,0.0002026907,0.001079712,0.00006966119,0.0004040622,0.000003302776,0.0001919326,0.002815095,0.9029083,0.00008794333,0.004015403,0.08602921],"study_design_scores_gemma":[0.03017745,0.0007497969,0.002936502,0.00005083431,0.0009118143,0.00004365983,0.00002345721,0.4694936,0.4271602,0.0006142679,0.06715035,0.0006880766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853761,0.003397863,0.004094827,0.004202303,0.0007953013,0.001626606,0.00005600637,0.0001669215,0.0002840593],"genre_scores_gemma":[0.9708166,0.007660711,0.001481535,0.01652078,0.001153274,0.0009559906,0.0000566311,0.00006910038,0.001285419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4757482,"threshold_uncertainty_score":0.9999733,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2769776705","doi":"10.1007/s00280-017-3477-4","title":"Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Medicine; Chemotherapy; Immunohistochemistry; Oncology; Internal medicine; Metastasis; Pancreatic ductal adenocarcinoma; Cancer research; Cancer; Pancreatic cancer","authors":[{"name":"Bolag Altan","is_ca":false},{"name":"Kyoichi Kaira","is_ca":false},{"name":"Akira Watanabe","is_ca":false},{"name":"Norio Kubo","is_ca":false},{"name":"Pinjie Bao","is_ca":false},{"name":"Dolgormaa Gantumur","is_ca":false},{"name":"Bilguun Erkhem‐Ochir","is_ca":false},{"name":"Kenichiro Araki","is_ca":false},{"name":"Yoshikatsu Kanai","is_ca":false},{"name":"Takehiko Yokobori","is_ca":false},{"name":"Tetsunari Oyama","is_ca":false},{"name":"Masahiko Nishiyama","is_ca":false},{"name":"Hiroyuki Kuwano","is_ca":false},{"name":"Ken Shirabe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02471767698518093,"gpt":0.3291384125174103,"spread":0.3044207355322293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013843,0.0001676483,0.000227642,0.00004368782,0.0002071271,0.00003037252,0.000175762,0.0001630845,0.00005606189],"category_scores_gemma":[0.00002134722,0.000160456,0.00002942599,0.00003675825,0.0001482643,0.00001306645,0.00006843935,0.0001234745,0.00000126205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001486289,"about_ca_system_score_gemma":0.00003901226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003297965,"about_ca_topic_score_gemma":0.00004870606,"domain_scores_codex":[0.999087,0.00004939693,0.0001636014,0.0003958533,0.00005807323,0.0002460673],"domain_scores_gemma":[0.9994714,0.00002895289,0.00009831929,0.0002467533,0.00002412655,0.0001304049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003039124,0.00001314178,0.6271127,0.00002784104,0.0000220368,0.000002700456,0.0002636604,8.439219e-7,0.3686792,0.00006988835,0.002320315,0.001183765],"study_design_scores_gemma":[0.002136488,0.00005731341,0.7641388,0.00002037377,0.00002042959,0.000003149765,0.00002157324,0.000002224636,0.2032225,0.0003171477,0.02988436,0.0001755888],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860781,0.01007371,0.0001113936,0.002810668,0.0001758682,0.0002655277,0.00001974086,0.000007772495,0.0004571439],"genre_scores_gemma":[0.9920805,0.003282351,0.0005697285,0.001841253,0.000672487,0.00007950464,0.00001052628,0.00002615651,0.001437567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1654567,"threshold_uncertainty_score":0.6543204,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014514137","doi":"10.1007/s00280-005-0155-8","title":"Antiproliferative and Antiproteolytic activity of Pentoxifylline in cultures of B16F10 Melanoma cells","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pentoxifylline; Chemistry; Matrix metalloproteinase; Pharmacology; Zymography; Extracellular matrix; MTT assay; Cell adhesion; Cell growth; In vitro; Cytotoxicity; Cell culture; Molecular biology; Cell; Biochemistry; Biology","authors":[{"name":"Pooja Dua","is_ca":true},{"name":"Rajiv P. Gude","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008637095251625556,"gpt":0.2991862646148014,"spread":0.2905491693631759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009529293,0.0001152941,0.0002135365,0.00003571885,0.00002008615,0.000002518161,0.00005937714,0.0001168339,0.00009154],"category_scores_gemma":[0.000002606511,0.000101068,0.00003068009,0.00005098447,0.0001240864,0.000007516675,0.00003054212,0.00007776754,1.783316e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007359062,"about_ca_system_score_gemma":0.00004339916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002790636,"about_ca_topic_score_gemma":0.00002056521,"domain_scores_codex":[0.999409,0.00005172977,0.0001509204,0.000211129,0.00004500005,0.0001322563],"domain_scores_gemma":[0.99974,0.000008610432,0.0001031138,0.00006890425,0.0000371623,0.00004223055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005903941,0.0001072838,0.001305135,0.00006399752,0.00005683682,7.53302e-7,0.0002035457,0.00001571389,0.991289,0.00001944696,0.0003970043,0.005950898],"study_design_scores_gemma":[0.001916099,0.0003180779,0.0006219948,0.00001605623,0.00001435672,0.000003171192,0.00001521646,0.0002191966,0.9929401,0.00004235041,0.003792208,0.0001011582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944859,0.004517229,0.0001249004,0.0003911863,0.0000689895,0.0002775424,0.00002909802,0.000002548629,0.0001026661],"genre_scores_gemma":[0.9923203,0.006480115,0.0002541209,0.0006182565,0.0001953242,0.0000302661,0.000003555913,0.000009316629,0.00008876698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00584974,"threshold_uncertainty_score":0.4121432,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075881224","doi":"10.1007/s00280-007-0544-2","title":"Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand","year":2007,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Synthesis and pharmacology of benzodiazepine derivatives","field":"Chemistry","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacology; In vivo; Glioma; Receptor; Cell culture; Chemistry; Biology; Cancer research; Biochemistry; Genetics","authors":[{"name":"Henriette Gourdeau","is_ca":false},{"name":"James B. McAlpine","is_ca":false},{"name":"Maxime Ranger","is_ca":false},{"name":"Bryan Simard","is_ca":false},{"name":"François Berger","is_ca":false},{"name":"Francis Beaudry","is_ca":true},{"name":"Pierre Falardeau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01661777123968933,"gpt":0.3031539496841207,"spread":0.2865361784444314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002976057,0.0002038664,0.0003509461,0.0000703961,0.0001393131,0.00001670182,0.000106792,0.0001493611,0.001105124],"category_scores_gemma":[0.00001464314,0.0002075113,0.00005831027,0.00009379995,0.000261649,0.0001416821,0.00002340366,0.0001265683,5.127054e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004257722,"about_ca_system_score_gemma":0.00005203419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001524178,"about_ca_topic_score_gemma":0.000004654163,"domain_scores_codex":[0.9989278,0.00001941374,0.0003328705,0.0003727396,0.00007829109,0.0002688745],"domain_scores_gemma":[0.9991843,0.0001687564,0.000319163,0.00009458944,0.0001244169,0.000108755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000812836,0.0001999313,0.003118724,0.0002678909,0.000189118,5.479213e-7,0.0006907173,0.000002405643,0.9332615,0.00004690258,0.0003238614,0.06108553],"study_design_scores_gemma":[0.002531961,0.0000508267,0.02098399,0.00002543685,0.00006752755,0.000005529585,0.00004500334,0.00046645,0.9525695,0.00002003172,0.02303162,0.0002020743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911895,0.0009684965,0.005053554,0.001719738,0.0003802151,0.0002453936,0.000309866,0.00003264413,0.0001006211],"genre_scores_gemma":[0.9938133,0.003871277,0.0002968712,0.0008354354,0.0005797627,0.00009435586,0.00004791543,0.00002920439,0.0004318334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06088346,"threshold_uncertainty_score":0.999808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150807070","doi":"10.1007/s00280-007-0522-8","title":"Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo","year":2007,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"National Science Council","keywords":"In vivo; Apoptosis; Growth inhibition; In vitro; Cervical carcinoma; Cancer research; Hsp90; Biology; Pharmacology; Chemistry; Internal medicine; Medicine; Cervical cancer; Cancer; Heat shock protein; Gene; Biochemistry; Genetics","authors":[{"name":"Joerg Schwock","is_ca":true},{"name":"Nhu‐An Pham","is_ca":true},{"name":"Mary Ping-Jiang Cao","is_ca":true},{"name":"David W. Hedley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01612579595384915,"gpt":0.3175938469495421,"spread":0.301468050995693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003329179,0.00008088272,0.0001984469,0.0001733106,0.000009916328,0.000001336377,0.00002476434,0.0001717833,0.00001103757],"category_scores_gemma":[0.00001101851,0.00008561579,0.00001906557,0.0001461413,0.0001498951,0.000006794855,0.00002513259,0.00008977456,1.035731e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002698075,"about_ca_system_score_gemma":0.00004648073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002717223,"about_ca_topic_score_gemma":0.00009075678,"domain_scores_codex":[0.9992609,0.00005857471,0.0002715278,0.000201328,0.00005017069,0.0001574817],"domain_scores_gemma":[0.9997542,0.00004578125,0.00006779293,0.00004233334,0.00005289185,0.00003703319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003611505,0.0002470087,0.00640277,0.0003200208,0.00001113351,6.026212e-7,0.0002912356,0.000004049661,0.9840031,0.000005397912,0.00001746597,0.005085677],"study_design_scores_gemma":[0.008609644,0.0002737483,0.01223632,0.00002918594,0.000005234068,0.000001297034,0.00005359969,0.0000529274,0.978552,0.00005298276,0.00006597365,0.00006710677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984169,0.0007373624,0.0001064015,0.0001722942,0.000031041,0.0004861023,0.00003010465,9.522824e-7,0.0000188439],"genre_scores_gemma":[0.9980414,0.00158122,0.0001598512,0.0000946021,0.000051037,0.00004842836,0.00001005984,0.000009192331,0.000004244231],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005833551,"threshold_uncertainty_score":0.349131,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035008632","doi":"10.1007/s00280-009-1182-7","title":"Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Cancer Research Society","keywords":"Sulforaphane; Cancer cell; Cancer research; Cytotoxic T cell; Biology; Cancer; Cell culture; Pharmacology; Biochemistry; In vitro; Genetics","authors":[{"name":"Liangao Hu","is_ca":true},{"name":"Weimin Miao","is_ca":true},{"name":"Martin Loignon","is_ca":true},{"name":"Mustapha Kandouz","is_ca":true},{"name":"Gerald Batist","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0103327370997558,"gpt":0.3022357120028151,"spread":0.2919029749030593,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000184321,0.0003489969,0.0004273103,0.00009316676,0.000101529,0.00001905107,0.0002509986,0.000215802,0.00005990586],"category_scores_gemma":[0.000008122178,0.000367353,0.00006841132,0.0001874821,0.0001563916,0.000013977,0.00006010302,0.0002373909,6.412907e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001640971,"about_ca_system_score_gemma":0.0001183279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009265631,"about_ca_topic_score_gemma":0.003110483,"domain_scores_codex":[0.9981381,0.0001945638,0.0004052002,0.0006832095,0.00008766615,0.00049127],"domain_scores_gemma":[0.9993451,0.00003490397,0.0001895468,0.0001940377,0.0000823322,0.0001540433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001324194,0.0002508817,0.002682641,0.00005544488,0.00004981345,0.00001258557,0.002138535,0.0002713825,0.9909316,0.0000136569,0.0008710799,0.001398199],"study_design_scores_gemma":[0.004341901,0.0001866167,0.009242931,0.00005714799,0.00002134868,9.176861e-7,0.0002729584,0.00003784634,0.9826415,0.0006355634,0.002149927,0.0004112939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837826,0.01378398,0.00001574023,0.001127172,0.00009077678,0.000629574,0.0001684507,0.00001398608,0.0003877016],"genre_scores_gemma":[0.9872056,0.005726817,0.0002546014,0.005699705,0.000277921,0.0001896479,0.0001034082,0.00003822187,0.0005040713],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008290038,"threshold_uncertainty_score":0.9998779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2323158095","doi":"10.1007/s00280-016-3018-6","title":"Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice","year":2016,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo","funders":"National Cancer Institute; U.S. Public Health Service; American Lebanese Syrian Associated Charities","keywords":"Physiologically based pharmacokinetic modelling; Sorafenib; Multidrug resistance-associated protein 2; Pharmacology; Pharmacokinetics; Transporter; Efflux; Chemistry; CYP3A4; Metabolite; Organic anion-transporting polypeptide; Glucuronide; Abcg2; In vivo; ATP-binding cassette transporter; Cytochrome P450; Biology; Metabolism; Biochemistry; Cancer research; Hepatocellular carcinoma","authors":[{"name":"Andrea N. Edginton","is_ca":true},{"name":"Eric I. Zimmerman","is_ca":false},{"name":"Aksana Vasilyeva","is_ca":false},{"name":"Sharyn D. Baker","is_ca":false},{"name":"John C. Panetta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0252176359212309,"gpt":0.3158128357228615,"spread":0.2905951998016306,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001182746,0.0001432024,0.0003213366,0.00006405236,0.00003932533,0.000003055756,0.00002864728,0.0001051547,0.0001800405],"category_scores_gemma":[0.000002083897,0.00009252517,0.00003136648,0.00006166138,0.0000883086,0.00005760256,0.000003128188,0.0000964827,2.376252e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001894145,"about_ca_system_score_gemma":0.00003382934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001876,"about_ca_topic_score_gemma":0.00002469014,"domain_scores_codex":[0.9992237,0.00003127186,0.0002065406,0.0002915223,0.00005938131,0.0001875936],"domain_scores_gemma":[0.9997289,0.00005666938,0.00004559771,0.00004669169,0.00002819031,0.00009391108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002985453,0.0001046344,0.009959829,0.0002066341,0.00007107911,0.00001946321,0.0004232756,0.001258114,0.9584454,0.00002903676,0.00000692249,0.02649015],"study_design_scores_gemma":[0.0663625,0.0007423424,0.1003688,0.001010756,0.0009363019,0.00001707295,0.0001638693,0.4504126,0.3641368,0.003738704,0.01099002,0.0011203],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856561,0.003205095,0.007613556,0.003034541,0.0001258306,0.0003050769,0.00001011583,0.00002689173,0.0000227908],"genre_scores_gemma":[0.9883447,0.008108553,0.0004648136,0.00282529,0.0001120655,0.00003974413,0.000004640394,0.00001590203,0.00008435119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5943087,"threshold_uncertainty_score":0.3773067,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1998295128","doi":"10.1007/s00280-009-0965-1","title":"Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia; University of British Columbia Hospital; Vancouver General Hospital","funders":"Health Canada","keywords":"Biodistribution; Pharmacokinetics; Prostate cancer; In vivo; Medicine; Cancer; Prostate; Pharmacology; Distribution (mathematics); Oncology; Internal medicine; Biology; Mathematics","authors":[{"name":"Alain G. Musende","is_ca":true},{"name":"Andy Eberding","is_ca":true},{"name":"Catherine A. Wood","is_ca":true},{"name":"Hans Adomat","is_ca":true},{"name":"Ladan Fazli","is_ca":true},{"name":"Antonio Hurtado‐Coll","is_ca":true},{"name":"William Jia","is_ca":true},{"name":"Marcel B. Bally","is_ca":true},{"name":"Emma Tomlinson Guns","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04347664029488311,"gpt":0.4315106341974881,"spread":0.388033993902605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004704173,0.0001147702,0.0001873059,0.00003776656,0.00004342939,0.000005415592,0.00005861019,0.0001423229,0.00003473007],"category_scores_gemma":[0.00001428473,0.0001029676,0.00003585572,0.00007929859,0.00009269684,0.000005339548,0.00001267425,0.00007988609,3.685862e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002463494,"about_ca_system_score_gemma":0.00006337526,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003186957,"about_ca_topic_score_gemma":0.00006707339,"domain_scores_codex":[0.9991025,0.00007853052,0.0003010818,0.0002977465,0.0000541736,0.0001659409],"domain_scores_gemma":[0.9996361,0.00003084092,0.0001131651,0.00006778625,0.0001048231,0.00004735842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005109787,0.0002141883,0.01019828,0.00002808453,0.00002694258,6.276497e-8,0.0001220182,0.003979396,0.9080779,0.00003831727,0.0004774041,0.07632641],"study_design_scores_gemma":[0.01516147,0.0007935863,0.1308617,0.00003931785,0.0001099267,8.608385e-7,0.000009988001,0.2293532,0.6177586,0.001288714,0.004337688,0.0002849383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944833,0.002725823,0.0005913088,0.0008901396,0.00004967994,0.001096315,0.0001420976,0.000005134944,0.0000162355],"genre_scores_gemma":[0.9925088,0.006190866,0.00008502636,0.0006996351,0.0001112448,0.00030087,0.00006692931,0.00000659534,0.00003002676],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2903194,"threshold_uncertainty_score":0.4198898,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040107189","doi":"10.1007/s00280-004-0843-9","title":"Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGF?-RII, KRAS2, TP53 and/or CDNK2A","year":2004,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal General Hospital; McGill University Health Centre; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Cancer research; Radiosensitivity; Ovarian cancer; Biology; Cancer; Cell culture; Oncology; Internal medicine; Medicine; Pathology; Radiation therapy; Genetics","authors":[{"name":"Christine M. Maugard","is_ca":true},{"name":"Marc Jolicoeur","is_ca":true},{"name":"Richard Bertrand","is_ca":true},{"name":"Suzanna L. Arcand","is_ca":true},{"name":"Patricia N. Tonin","is_ca":true},{"name":"Diane Provencher","is_ca":true},{"name":"Anne‐Marie Mes‐Masson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02130002559684653,"gpt":0.3164080200461256,"spread":0.2951079944492791,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001551944,0.0002461655,0.0003208451,0.00005796133,0.000140806,0.00002066613,0.00007435525,0.0002001582,0.0001169267],"category_scores_gemma":[0.00001123762,0.000243204,0.0000419822,0.0001161114,0.0002767513,0.00001743644,0.00006387874,0.0001516915,2.000186e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009910652,"about_ca_system_score_gemma":0.0004745571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001691803,"about_ca_topic_score_gemma":0.002727934,"domain_scores_codex":[0.9987156,0.0000935117,0.0003009402,0.0005222391,0.00007734996,0.0002903741],"domain_scores_gemma":[0.9994601,0.00004074356,0.0001594967,0.0001391908,0.00008183036,0.0001186562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003300519,0.00007766905,0.002990817,0.0001091428,0.00008938595,0.00001113093,0.0008626573,0.0004973077,0.9773564,0.00001538856,0.0003448115,0.01731523],"study_design_scores_gemma":[0.00502347,0.0001919851,0.0135139,0.00004894607,0.00006338058,0.00005676234,0.0000882798,0.0002062317,0.978786,0.000172071,0.001566911,0.0002820597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906571,0.006204145,0.0004896799,0.001763539,0.0002348562,0.0004453001,0.0001060029,0.00001222655,0.00008714344],"genre_scores_gemma":[0.9875966,0.007720901,0.002008229,0.001372695,0.000931398,0.00009079721,0.00001888773,0.00003654426,0.0002238935],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01703317,"threshold_uncertainty_score":0.9917573,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047405239","doi":"10.1007/s00280-005-0161-x","title":"Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lipid Membrane Structure and Behavior","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Liposome; In vivo; Pharmacokinetics; Bioavailability; Chemistry; Ethylene glycol; PEG ratio; Pharmacology; Toxicity; Drug; Phosphatidylcholine; Drug delivery; Solubility; Chromatography; Medicine; Biochemistry; Phospholipid; Biology; Organic chemistry; Membrane","authors":[{"name":"Jubo Liu","is_ca":true},{"name":"Helen Lee","is_ca":true},{"name":"Mario Huesca","is_ca":false},{"name":"Aiping Young","is_ca":false},{"name":"Christine Allen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02425954105668785,"gpt":0.3342592471305177,"spread":0.3099997060738298,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005876849,0.0001709431,0.0002369374,0.00003911235,0.00007429983,0.000007295765,0.0001135679,0.0001550874,0.0002462839],"category_scores_gemma":[0.000001213373,0.0001503537,0.00008861868,0.00005768124,0.00008715571,0.00001015908,0.00001767644,0.00006863754,2.893776e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001647093,"about_ca_system_score_gemma":0.00007356572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001746164,"about_ca_topic_score_gemma":0.00001376766,"domain_scores_codex":[0.9992249,0.00001062928,0.0002045433,0.0002807582,0.00006033481,0.0002188146],"domain_scores_gemma":[0.9996077,0.00001744309,0.000125285,0.0001107405,0.00008007266,0.00005870717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006177052,0.000157174,0.00156299,0.00004561929,0.000133122,8.011808e-8,0.000146682,0.0002182912,0.9724337,0.0000147887,0.001030255,0.02363955],"study_design_scores_gemma":[0.004370669,0.0002016511,0.000762978,0.000007255815,0.00004079777,0.00000365261,0.000008197759,0.0004139215,0.8852935,0.000006186353,0.1087275,0.0001636822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945509,0.00332801,0.0002549303,0.0008328046,0.0003940751,0.0004763916,0.0001127414,0.00001038103,0.00003974024],"genre_scores_gemma":[0.9877382,0.007385069,0.0003476088,0.002592922,0.00140453,0.0001759199,0.00005161453,0.00002938498,0.0002747496],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1076972,"threshold_uncertainty_score":0.6131244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016501792","doi":"10.1007/s002800050037","title":"Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G 2 arrest","year":2000,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Camptothecin; Cytotoxicity; Cancer research; Pharmacology; Breast cancer; Chemistry; Medicine; Cancer; Internal medicine; In vitro; Biochemistry","authors":[{"name":"Carleton Jones","is_ca":false},{"name":"Mark K Clements","is_ca":false},{"name":"Safia Wasi","is_ca":true},{"name":"Sayed S. Daoud","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009885625366621123,"gpt":0.2871396625869477,"spread":0.2772540372203266,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008936549,0.0001572527,0.0002418563,0.00004072364,0.00002645445,0.000003269516,0.0001046037,0.0001131865,0.001835718],"category_scores_gemma":[2.227481e-7,0.0001402458,0.00003926321,0.0001106318,0.00009825035,0.000005193066,0.00001237667,0.00008038632,4.080131e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003738175,"about_ca_system_score_gemma":0.0001383328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004464497,"about_ca_topic_score_gemma":0.0002993408,"domain_scores_codex":[0.9991671,0.00003973874,0.0002252828,0.0002787774,0.00008574886,0.0002033497],"domain_scores_gemma":[0.9996265,0.000008251473,0.0001306246,0.0001249139,0.00005531757,0.00005438896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00181663,0.0001539237,0.0009277744,0.00006420042,0.0001368808,7.67846e-7,0.0002643237,0.0001468871,0.9666252,0.000009183863,0.0001236221,0.02973056],"study_design_scores_gemma":[0.002942381,0.0003448948,0.001403012,0.00004191678,0.00003489214,0.000003004287,0.00003166551,0.00008395402,0.9902772,0.0000251043,0.004658255,0.0001536821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974724,0.001311367,0.0001063046,0.0003680475,0.000175916,0.0002936483,0.00008335934,0.000003581142,0.0001853876],"genre_scores_gemma":[0.9816256,0.01668948,0.00007817114,0.001127205,0.0001702401,0.0001110213,0.000009425133,0.00002096026,0.000167968],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02957688,"threshold_uncertainty_score":0.9990767,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963733180","doi":"10.1007/s00280-005-0035-2","title":"Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Neutropenia; Pharmacodynamics; Population; Pharmacokinetics; Nadir; Internal medicine; Dosing; Body surface area; Pemetrexed; Incidence (geometry); Pharmacology; Oncology; Chemotherapy","authors":[{"name":"Jane E. Latz","is_ca":false},{"name":"James J. Rusthoven","is_ca":true},{"name":"Mats O. Karlsson","is_ca":false},{"name":"Atalanta Ghosh","is_ca":false},{"name":"Robert D. Johnson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05261056602320502,"gpt":0.4237755880792898,"spread":0.3711650220560848,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001823885,0.0001450066,0.0004161677,0.00005837711,0.00009440089,0.000004935911,0.00006687616,0.0001288018,0.0001502131],"category_scores_gemma":[0.000004644772,0.0001238508,0.0001808487,0.0001224184,0.00005443725,0.00006496167,0.00001094638,0.0001369123,0.000001467821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006350923,"about_ca_system_score_gemma":0.00007666377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003751817,"about_ca_topic_score_gemma":0.00001449367,"domain_scores_codex":[0.9990339,0.00004140918,0.0003533626,0.0003137945,0.00007027912,0.0001872394],"domain_scores_gemma":[0.9994507,0.0000914127,0.0001645916,0.0001271866,0.00008007855,0.00008604975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002345532,0.0002943225,0.01361881,0.00006766543,0.0002901452,3.626951e-7,0.0001382009,0.0007551954,0.786845,0.0003010674,0.001576127,0.1937675],"study_design_scores_gemma":[0.04091412,0.002570594,0.0462054,0.00008055694,0.001118236,0.00001872458,0.00004978804,0.3854494,0.441733,0.003154047,0.07795423,0.0007518845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779818,0.001541586,0.01718261,0.001629532,0.0003195677,0.001161231,0.00002347781,0.00005077668,0.0001094308],"genre_scores_gemma":[0.9873115,0.003542763,0.002303888,0.005280284,0.0006960687,0.0005407275,0.00003281881,0.0000273557,0.0002646124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3846942,"threshold_uncertainty_score":0.5050489,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052488949","doi":"10.1007/s002800000231","title":"Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all- trans -retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells","year":2001,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Steacie Institute for Molecular Sciences; McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Connexin; Retinoic acid; Downregulation and upregulation; Intracellular; Gap junction; Neuroblastoma; Glutathione; Chemistry; Cell biology; Tretinoin; Biology; Cell culture; Biochemistry; Enzyme; Gene; Genetics","authors":[{"name":"George D. Carystinos","is_ca":true},{"name":"Moulay A. Alaoui‐Jamali","is_ca":true},{"name":"Jenny Phipps","is_ca":true},{"name":"Lily Yen","is_ca":true},{"name":"Gerald Batist","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0142337403151128,"gpt":0.2694739558026567,"spread":0.2552402154875439,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001552924,0.0001434938,0.0001975024,0.00003856911,0.00005777282,0.000007583216,0.00003810168,0.0001834294,0.00006702697],"category_scores_gemma":[0.000004665029,0.0001336732,0.00001690353,0.00005336035,0.0002749635,0.00001075478,0.00003147912,0.0001115248,6.27609e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001259037,"about_ca_system_score_gemma":0.000016002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004596658,"about_ca_topic_score_gemma":0.0001326885,"domain_scores_codex":[0.9991833,0.0001656945,0.0001672711,0.0003006872,0.00004324682,0.0001397852],"domain_scores_gemma":[0.9996594,0.00004598033,0.0001122089,0.00008576441,0.00004383224,0.00005277989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001071208,0.00007022062,0.005533272,0.00002141601,0.00006421084,0.00000100088,0.0004856606,0.000006336169,0.9879614,0.000003348849,0.000358129,0.004423762],"study_design_scores_gemma":[0.00348847,0.0003369063,0.0144421,0.00003535638,0.00003747628,0.00003246951,0.0000519601,0.0005421627,0.9728528,0.00004309604,0.007973705,0.0001635194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948704,0.003134972,0.0004925935,0.001199566,0.00003476003,0.0001997096,0.00003508093,0.000006590731,0.00002635194],"genre_scores_gemma":[0.9858579,0.01257991,0.00007051069,0.001267462,0.00003015799,0.00002048069,0.0001040992,0.00001353072,0.00005593035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01510865,"threshold_uncertainty_score":0.5451033,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083324782","doi":"10.1007/s00280-006-0343-1","title":"Class III β-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site","year":2006,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Hospices Civils de Lyon","keywords":"Paclitaxel; Tubulin; Cancer research; Primary (astronomy); Oncology; Class (philosophy); Internal medicine; Medicine; Biology; Microtubule; Chemotherapy; Genetics; Computer science","authors":[{"name":"P. Sève","is_ca":false},{"name":"Tony Reiman","is_ca":true},{"name":"Raymond Lai","is_ca":true},{"name":"John Hanson","is_ca":true},{"name":"C.L. Santos","is_ca":true},{"name":"Lorelei Johnson","is_ca":true},{"name":"Laith Dabbagh","is_ca":true},{"name":"Michael Sawyer","is_ca":true},{"name":"Charles Dumontet","is_ca":false},{"name":"John R. Mackey","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01122150656591544,"gpt":0.293799886724627,"spread":0.2825783801587116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009953045,0.0001478093,0.0005068502,0.00009027856,0.00001802602,0.00000185326,0.0000429694,0.00009369131,0.001227418],"category_scores_gemma":[0.0000013848,0.0001306281,0.00008265775,0.0001853918,0.0001688135,0.00002939744,0.00001430763,0.0001063237,6.521653e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001922938,"about_ca_system_score_gemma":0.0001950907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001106115,"about_ca_topic_score_gemma":0.000639669,"domain_scores_codex":[0.9990499,0.00003514835,0.000350175,0.0002591905,0.0001069964,0.0001986033],"domain_scores_gemma":[0.9995044,0.00008337547,0.0001510342,0.0001285009,0.00006689505,0.00006575126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007214523,0.001305248,0.6510362,0.001284013,0.0004190066,0.00005775813,0.00175202,0.00000997192,0.2620285,0.0002883673,0.06333046,0.01127391],"study_design_scores_gemma":[0.01684503,0.0002855053,0.5439948,0.0002075148,0.0002114292,0.000005299716,0.00002467026,0.00003825151,0.3002019,0.0002338298,0.1377865,0.0001652585],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9540971,0.03650453,0.000003832964,0.004521844,0.00012652,0.0003967052,0.00007249718,0.000008140398,0.004268833],"genre_scores_gemma":[0.9834934,0.01062515,0.0001673369,0.00374326,0.0001533192,0.0001197856,0.0000146263,0.00001821016,0.001664876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1070414,"threshold_uncertainty_score":0.9996856,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991404956","doi":"10.1007/s00280-010-1342-9","title":"Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Calicheamicin; Immunoconjugate; CD22; Chemotherapy; CHOP; Cancer research; Medicine; Monoclonal antibody; Antibody; Internal medicine; Immunology","authors":[{"name":"John F. DiJoseph","is_ca":true},{"name":"Maureen Dougher","is_ca":false},{"name":"Deborah Y. Evans","is_ca":false},{"name":"Bin‐Bing S. Zhou","is_ca":false},{"name":"Nitin K. Damle","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01762662808946152,"gpt":0.3344375505906821,"spread":0.3168109225012206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002741101,0.0006787116,0.001743252,0.0002131739,0.0001464192,0.00002285101,0.0002362042,0.0002790659,0.001399169],"category_scores_gemma":[0.000005431643,0.0004315304,0.0001473446,0.0005728886,0.001027338,0.0001818361,0.00002312484,0.0005342378,0.000002112159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001844618,"about_ca_system_score_gemma":0.0007330073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006348733,"about_ca_topic_score_gemma":0.0001331677,"domain_scores_codex":[0.9973229,0.0001187565,0.0006823275,0.000851692,0.0004214747,0.0006028441],"domain_scores_gemma":[0.9976062,0.0002715019,0.0008134986,0.0005412048,0.0004986918,0.0002689108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04719944,0.003857173,0.1128341,0.0003791729,0.002148697,0.00006304301,0.001341261,0.00001798096,0.821379,0.00001364006,0.0005749157,0.0101916],"study_design_scores_gemma":[0.05991343,0.004572905,0.2544332,0.000255125,0.0003431663,0.0001398958,0.00008264979,0.0006544868,0.6769153,0.000007965986,0.002282228,0.0003996558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936672,0.0009605626,0.0002344259,0.002188054,0.000255356,0.002373947,0.0001041469,0.00008145095,0.0001348016],"genre_scores_gemma":[0.9907351,0.005086237,0.001206445,0.002221798,0.0002027391,0.0002402873,0.00007970523,0.000126933,0.0001008158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1444638,"threshold_uncertainty_score":0.9998137,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095031513","doi":"10.1007/s00280-012-1889-8","title":"A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Institut national de la recherche scientifique; Amgen","keywords":"Everolimus; Bevacizumab; Panitumumab; Solid tumor; Medicine; Oncology; Internal medicine; Cancer research; Chemotherapy; Cancer; Colorectal cancer; KRAS","authors":[{"name":"Gordana Vlahovic","is_ca":false},{"name":"Kellen L. Meadows","is_ca":false},{"name":"Hope E. Uronis","is_ca":false},{"name":"Michael A. Morse","is_ca":false},{"name":"Gerard C. Blobe","is_ca":false},{"name":"Richard F. Riedel","is_ca":false},{"name":"S. Yousuf Zafar","is_ca":false},{"name":"A. Alvarez-Secord","is_ca":false},{"name":"Jon P. Gockerman","is_ca":false},{"name":"Alexander Starodub","is_ca":false},{"name":"Neal Ready","is_ca":false},{"name":"Élizabeth Anderson","is_ca":false},{"name":"Johanna C. Bendell","is_ca":false},{"name":"Herbert I. Hurwitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01769403803337643,"gpt":0.3676464043998438,"spread":0.3499523663664674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001695018,0.0001818546,0.0002911652,0.00005966106,0.00004293551,0.000004532708,0.000108024,0.0001050564,0.0001352614],"category_scores_gemma":[0.000006542152,0.000180764,0.00002801418,0.00009498822,0.000145619,0.00001112455,0.0000515218,0.0001233628,4.259507e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003159275,"about_ca_system_score_gemma":0.00006261694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000504591,"about_ca_topic_score_gemma":0.0000346159,"domain_scores_codex":[0.99896,0.00008679703,0.0002512665,0.000301701,0.0000739077,0.0003263821],"domain_scores_gemma":[0.9995753,0.00002100406,0.0001219329,0.0001324744,0.00004108857,0.0001082272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001805643,0.001016036,0.01762492,0.0000539477,0.0001265197,0.000003040737,0.001675592,0.00004750119,0.952681,0.000003417039,0.0002645166,0.02469785],"study_design_scores_gemma":[0.02377674,0.002619117,0.00522897,0.00002004955,0.00006381537,0.00001770649,0.000491653,0.00008842928,0.9592952,0.00002823428,0.008066293,0.0003038686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988189,0.0108553,0.00002599393,0.00009758696,0.0003287683,0.000406772,0.00002045816,0.000008011562,0.00006813624],"genre_scores_gemma":[0.9965271,0.001994379,0.00005311313,0.0008584118,0.0003149871,0.0001615404,0.000006350684,0.00002705638,0.00005705108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02439398,"threshold_uncertainty_score":0.7371341,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2773849850","doi":"10.1007/s00280-017-3494-3","title":"Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors","year":2017,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"Mirati Therapeutics","keywords":"Gemcitabine; Medicine; Pancreatic cancer; Internal medicine; Adverse effect; Cancer; Clinical endpoint; Phases of clinical research; Gastroenterology; Maximum tolerated dose; Oncology; Clinical trial","authors":[{"name":"Emily Chan","is_ca":false},{"name":"E. Gabriela Chiorean","is_ca":false},{"name":"Peter J. O’Dwyer","is_ca":false},{"name":"Nashat Gabrail","is_ca":false},{"name":"Thierry Alcindor","is_ca":true},{"name":"Diane Potvin","is_ca":false},{"name":"Richard C. Chao","is_ca":false},{"name":"Herbert I. Hurwitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01200696942343428,"gpt":0.3602316395150852,"spread":0.348224670091651,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009367196,0.0001751874,0.0002973058,0.00005566065,0.0001934124,0.00001039716,0.0001243566,0.00006180558,0.00002661268],"category_scores_gemma":[0.0000123895,0.0001422791,0.00001565718,0.00004829494,0.0002411192,0.00001633756,0.00005255169,0.0000851672,5.126385e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000339806,"about_ca_system_score_gemma":0.00008437236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001259706,"about_ca_topic_score_gemma":0.0003840354,"domain_scores_codex":[0.9990605,0.00003798786,0.0001844051,0.0003736267,0.0001018587,0.0002416666],"domain_scores_gemma":[0.9993567,0.00002143111,0.0002114364,0.0001840721,0.0001565581,0.00006984111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02199926,0.00372281,0.08138785,0.0002138356,0.000297868,0.000003556833,0.001700078,0.000162951,0.814177,0.000004221497,0.0002454594,0.07608514],"study_design_scores_gemma":[0.108239,0.02496862,0.01718621,0.0001183328,0.00007875208,0.000001886656,0.0002812892,0.0002500316,0.8447689,0.000013745,0.003714354,0.0003789069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973606,0.0007413276,0.00002459565,0.0002087816,0.00006715794,0.001472023,0.00008746211,0.00000459487,0.00003339],"genre_scores_gemma":[0.9980643,0.0006040481,0.0001291605,0.0002293138,0.00005381736,0.0007163346,0.00001904539,0.00003628813,0.000147734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08623969,"threshold_uncertainty_score":0.5801971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074046269","doi":"10.1007/s00280-005-0098-0","title":"Beyond simple castration: targeting the molecular basis of treatment resistance in advanced prostate cancer","year":2005,"lang":"en","type":"review","venue":"Cancer Chemotherapy and Pharmacology","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Prostate cancer; Androgen; Androgen receptor; Medicine; Cancer research; Clusterin; Cancer; Internal medicine; Oncology; Biology; Hormone; Apoptosis; Genetics","authors":[{"name":"Martin Gleave","is_ca":true},{"name":"Hideaki Miyake","is_ca":true},{"name":"Kim Chi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03139075232972255,"gpt":0.4092197528021406,"spread":0.3778290004724181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001377846,0.0003799295,0.001317387,0.0001046777,0.0000537706,0.000005652042,0.0001206886,0.000195504,0.001080428],"category_scores_gemma":[0.000007651247,0.0002655066,0.0001990299,0.0002687959,0.0002229914,0.00003286265,0.00002880314,0.0002640694,0.000001174116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005682327,"about_ca_system_score_gemma":0.0007490079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006127907,"about_ca_topic_score_gemma":0.0002142558,"domain_scores_codex":[0.9983006,0.0001978343,0.0005961661,0.0004768317,0.00009484278,0.0003337206],"domain_scores_gemma":[0.9990848,0.0001483134,0.0003837509,0.000221409,0.00006722927,0.00009448038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006226472,0.0001207697,0.0001717204,0.006040732,0.0004491151,0.00008430285,0.0007471322,0.00005101114,0.002195808,0.00001966703,0.001133026,0.988364],"study_design_scores_gemma":[0.003007681,0.0001645217,0.00004504994,0.001183317,0.000988525,0.00002270946,0.00003281219,0.00001543223,0.002116882,0.0000386847,0.9921663,0.0002181063],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01107265,0.9847053,0.000002885706,0.001486838,0.0002726732,0.001920133,0.0002367535,0.00001626569,0.0002865499],"genre_scores_gemma":[0.001379465,0.9939755,0.0002146836,0.001366872,0.0003681515,0.002075155,0.0000667612,0.00005973105,0.0004936877],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9910333,"threshold_uncertainty_score":0.9999797,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2604986769","doi":"10.1007/s00280-017-3298-5","title":"Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity","year":2017,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada","keywords":"Autophagy; Pantoprazole; Drug resistance; Pharmacology; Cancer research; Chemotherapy; Programmed cell death; Biology; Apoptosis; Chemistry; Biochemistry","authors":[{"name":"Qian Tan","is_ca":true},{"name":"Anthony M. Joshua","is_ca":true},{"name":"M. Wang","is_ca":true},{"name":"Robert G. Bristow","is_ca":true},{"name":"Bradly G. Wouters","is_ca":true},{"name":"Christine Allen","is_ca":true},{"name":"Ian F. Tannock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01377668115083513,"gpt":0.3230400342287358,"spread":0.3092633530779006,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002524625,0.0002290448,0.0005563284,0.0001015948,0.0001569322,0.00001335982,0.00009978931,0.0001178283,0.0005469595],"category_scores_gemma":[0.00001654013,0.0002204278,0.00005970865,0.0001278099,0.0002075773,0.00007746055,0.00004200953,0.0001156357,6.385632e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005651338,"about_ca_system_score_gemma":0.0001417875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007328063,"about_ca_topic_score_gemma":0.0001177836,"domain_scores_codex":[0.9988082,0.00007072951,0.000291285,0.0003974382,0.0001749228,0.0002574236],"domain_scores_gemma":[0.9988562,0.00006476376,0.0002608823,0.0003292575,0.0001776189,0.0003112515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003749928,0.000149471,0.00125156,0.0001799697,0.0002675587,0.00000755512,0.003829014,0.000001138944,0.9614877,0.0001443231,0.01642999,0.01250185],"study_design_scores_gemma":[0.00591632,0.0001910481,0.01621591,0.00009657782,0.0001068112,0.000006414386,0.00006557953,0.0001737679,0.9646841,0.0003489031,0.01200318,0.0001914007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805863,0.001212369,0.0001692052,0.01664321,0.0001764579,0.0007335252,0.0003036089,0.00002612584,0.0001492262],"genre_scores_gemma":[0.9732552,0.001957128,0.0002019031,0.02257605,0.0001386879,0.00006100431,0.00001383503,0.00003464461,0.001761574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01496435,"threshold_uncertainty_score":0.8988786,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2030098953","doi":"10.1007/s00280-006-0225-6","title":"Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2′-deoxycytidine (decitabine) on human breast carcinoma cells","year":2006,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Decitabine; Deoxycytidine; Histone deacetylase inhibitor; Chemistry; Cancer research; Histone deacetylase; Pharmacology; Azacitidine; Histone; Medicine; Internal medicine; Chemotherapy; DNA methylation; Biochemistry; DNA","authors":[{"name":"Annie Hurtubise","is_ca":true},{"name":"Richard L. Momparler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01136557177753556,"gpt":0.3456122280967449,"spread":0.3342466563192094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001529329,0.0001841101,0.000260236,0.00007443597,0.0000530566,0.000003357103,0.00006910222,0.0001524031,0.0000801705],"category_scores_gemma":[0.000003865701,0.0001662906,0.00007542291,0.00007632942,0.0001187776,0.000002957307,0.00001631615,0.00009178319,9.864626e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002794451,"about_ca_system_score_gemma":0.0000325103,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008999916,"about_ca_topic_score_gemma":0.00001429498,"domain_scores_codex":[0.9991007,0.0001075661,0.0002464474,0.0002854722,0.00009315275,0.000166653],"domain_scores_gemma":[0.9995076,0.00006201427,0.0001898171,0.0001290171,0.00006270982,0.0000488083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001545064,0.0003150155,0.001956545,0.0001446658,0.00004495601,0.000001239833,0.0000196771,0.0002690356,0.9902102,0.00001449731,0.0009512274,0.004527867],"study_design_scores_gemma":[0.005505969,0.00234967,0.004147882,0.00002117587,0.00004942499,0.000002230372,0.000002417035,0.00006524437,0.9856571,0.00001391401,0.002046229,0.0001387412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997538,0.001353168,0.00006424941,0.00009263811,0.0003993198,0.0002360392,0.00006509123,0.000006527137,0.0002449154],"genre_scores_gemma":[0.9983631,0.0005989206,0.00001901853,0.0001062788,0.0006005227,0.00002499639,0.00005215238,0.00002562556,0.0002094243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004553108,"threshold_uncertainty_score":0.6781136,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}